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Abstract 
The conception and realization of microfluidic Total Analysis Systems (microTAS) has revolutionized the 
analytical process by integrating the whole breadth of analytical techniques into miniaturized systems.  
Paramount for efficient and competitive microTAS are integrated detection strategies, which lead to low limits 
of detection while reducing the sample volume.  The concept of electrochemiluminescence (ECL) has been 
especially intriguing ever since the introduction of a version based on Ru(bpy)3
2+ 
by Alan Bard in 1972[1], due 
to its immense sensitivity, non-existent auto-luminescent background signal, and simplicity in experimental 
design.  Therefore, integrating ECL detection into microTAS is a logical consequence to achieve simple, yet 
highly sensitive sensors.   
ECL follows complex electron transfer pathways, and its efficiency can be enhanced, but also hindered, by 
numerous factors.  Our studies identified the novel combination of the coreactant N-butyldiethanolamine 
(NBEA) with the surfactant Zonyl FSN as an optimal signal enhancer for Ru(bpy)3
2+
-based ECL.  This 
combination of coreactant and surfactant led to a limit of detection (LOD) for Ru(bpy)3
2+ 
of 2.2 nM, compared to 
0.59 µM for the commonly used Tripropylamine/Triton X-100 system, and a 50-fold increase in sensitivity.  
Investigations under different buffer conditions revealed that the ECL signal was significantly influenced by 
buffer composition and pH values.  Furthermore it was possible to generate an ECL signal at a potential well 
below 1.2 V vs. Ag/AgCl, the common potential for Ru(bpy)3
2+
-based ECL.  The low oxidation potential (LOP) 
signal was significantly increased under the use of the coreactant NBEA with Tris buffer at pH 8.5, and was 
about three times higher than for the standard coreactant, TPA, in phosphate-based buffer at pH 7.  Such low 
potential ECL signals are desirable for electrode lifetime enhancement and prevention of possible DNA damage 
in bioassays.   
However, to truly extend a sensor’s limit of detection, one must go beyond a mere one-to-one labeling approach, 
especially when dealing with DNA, which, by its nature, is mostly present at low concentrations in real-life 
samples.  Liposomes, molecules capable of encapsulating large quantities of analyte and of being DNA-specific, 
offer a convenient way of enhancing detection capabilities.  Therefore, Ru(bpy)3
2+
encapsulating liposomes were 
successfully synthesized and linked to Cryptosporidium parvum (C. parvum) DNA.  ECL detection of the DNA 
was achieved inside a microfluidic chip with a microfabricated three electrode system.  After identification of the 
appropriate assay and flow parameters, it was possible to achieve on-chip ECL detection in less than ten minutes, 
while the microfluidic chip was also capable of fluorescent and electrochemical detection.   
The study not only presents a novel ECL-based microfluidic biosensor, but functioning strategies that are 
urgently required to increase its usability and sensitivity. 
 
Die Konzeptionierung und Realisierung von microfluidic Total Analysis Systems (microTAS) hat durch die Integrierung 
analytischer Techniken in miniaturisierte Systeme entscheident zur Revolutionierung von analytischen Prozessen 
beigetragen. Besonders wichtig sind hierbei Detektionsstrategien, die hohe Sensitivitaeten bei geringen Probekonzentrationen 
erlauben. Elektrochemilumineszenz (ECL) ist hierbei besonders interessant, durch den Wegfall eines Hintergrundsignals, 
seiner hohen Sensitivitaet und vereinfachtem experimentellem Design. Es ist somit eine logische Konsequenz ECL in 
microTAS zu integrieren um einfache und gleichzeitig sensitive Sensoren zu erhalten. 
ECL durchlaeuft komplexe Elektronentransferreaktionen, und seine Effizienz kann durch viele Faktoren positiv, aber auch 
negativ beeinflusst werden. In der vorgelegten Studie wurden N-butyldiethanolamine (NBEA) mit dem Tensid Zonyl FSN als 
optimale Signalverstaerker fuer Ru(bpy)3
2+-basierte ECL identifiziert und fuehrten zu einem Ru(bpy)3
2+ Detektionslimit von 
2.2 nM, im Vergleich zu nur 0.59 µM fuer das meist verwendete System aus Tripropylamine und Triton X-100, und 
gleichzeitig zu einer 50 mal hoeheren Sensitivitaet. Pufferbedingungen und pH zeigten einen starken Einfluss auf das ECL 
System mit der Moeglichkeit eines low oxidation potential (LOP) ECL Signals unter der Verwendung des Coreaktanten 
NBEA mit Tris Puffer bei pH 8.5, welches zu einem drei mal so starken ECL Signal fuehrt als der Standard Coreaktant TPA 
in phoshpathaltigem Puffer bei pH 7. Die Verwendung von LOP ECL spielt besonders eine Roller bei der Verlaengerung der 
Verwendungsdauer der Elektroden und der Verhinderung von moeglichen DNA Stoerungen durch zu hohe Spannungen.  
Um das Detektionslimit noch weiter zu verbessern, ist es essentiell mehrere Signaltraeger mit der Probe zu koppeln, 
besonders fuer DNA, die generell in natuerlichen Proben in niedrigen Konzentrationen vorliegt. Liposome, die eine grosse 
Anzahl an Molekuelen einschliessen koennen und sich spezifisch an DNA binden lassen, sind predestiniert fuer diesen 
Zweck, weshalb Ru(bpy)3
2+ einschliessende Liposome erfolgreich hergestellt wurden, die an Cryptosporidium parvum (C. 
parvum) DNA koppeln. Die DNA wurde per ECL in einem mikrofluidischen Chip mit integriertem drei-Elektroden-System 
detektiert. Nach der Identifizierung der geeigneten experimentellen- und Fliessparametern, war ECL Detektion im Chip in 
weniger als zehn Minuten moeglich, wobei der Chip auch fuer Fluoreszenz und EC Detektion nutzbar ist.  
Die vorliegende Studie praesentiert nicht nur einen neuartige ECL-basierten mikrofluidischen Biosensor, sondern auch 
funktionierende Strategien, um dessen Brauchbarkeit und Sensitivitaet zu erhoehen. 
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Aims 
Microfluidic devices, with their advantages of fast response and low sample consumption, are 
continuously being integrated into analytical applications.  However, herein also lies one of 
the biggest hurdles one needs to overcome in the development of a sensitive chip; the low 
analyte concentration.  For example, DNA, due to its generally low representation in real-life 
samples, requires detectors with low limits of detection.  Strategies addressing the problem of 
reduced signal intensity are therefore essential to allow for comparability to bench-top 
devices. 
Electrochemiluminescence (ECL), a process in which molecules emit photons upon excitation 
via an applied voltage, offers a strong tool to reach high sensitivity within a system.  ECL of 
Ru(bpy)3
2+
 is a complex process, and not entirely understood up to this point.  It is known, 
however, that certain environmental conditions can enhance the signal intensity of 
Ru(bpy)3
2+
-based ECL.  Most often, a so-called coreactant is present in solution, participating 
in the electron transfer reactions and facilitating the formation of the photon-emitting state of 
Ru(bpy)3
2+
.  Tripropylamine (TPA) is the most commonly-employed coreactant in the 
literature, though other coreactants, namely N-butyldiethanolamine (NBEA) and 2- 
(dibutylamino)ethanol (DBAE),  have been shown to enhance the ECL signal even further 
than TPA.  In addition, a surfactant, almost exclusively Triton X-100, is sometimes employed 
for the same purpose: signal enhancement.  Alternative surfactants have been investigated as 
well, and Zonyl FSN has been the most outstanding one compared to Triton X-100.  It is 
believed that the electrode surface is rendered more hydrophobic by the surfactant, allowing 
the hydrophobic TPA to be enriched in close proximity to the electrode, and facilitating the 
presence of more Ru(bpy)3
2+
 molecules in the photon-emitting excited state.  
Even though it has been demonstrated that DBAE and NBEA increase the ECL signal, no 
publication shows the two coreactants in combination with Triton X-100 or Zonyl FSN for 
Ru(bpy)3
2+
.  Also, a comparative study is missing.  We therefore investigated the effects of 
both surfactants, Triton X-100 and Zonyl FSN, in combination with the three coreactants, 
TPA, DBAE and N-Butyldiethanolamine, on Ru(bpy)3
2+
 ECL, with the intent to identify 
conditions under which the ECL signal can be even further increased, compared to the already 
investigated cases.  
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Another goal of this study was the fabrication of a transparent microfluidic device with 
integrated three-electrode configuration to achieve on-chip ECL detection of DNA sequences.  
In this study, Cryptosporidium parvum (C. parvum), a waterborne pathogen responsible for 
disease outbreaks worldwide, was chosen as model analyte.  In addition to detection via ECL, 
we also aim for a chip capable of electrochemical (EC) and fluorescent detection, to increase 
the capabilities of the device and to develop a system in which all three methods can be 
compared with each other under equivalent conditions.  
Relying on a sensitive detection technique is only one way to ensure high sensitivity.  Another 
approach is an increase in signaling molecules.  In the case of DNA, it is common to link the 
DNA to a labeling molecule, e.g. a fluorescent marker, or to Ru(bpy)3
2+
, the most common 
ECL molecule.  Under the best conditions, each DNA molecule would be linked to one 
marker molecule.  If, however, the DNA is linked to a molecule capable of accumulating 
multiple signaling molecules, the signal can be increased, and lower limits of detection are 
attainable.  Liposomes can be employed for such purposes.  They form a vesicle of a bilipid 
layer in which other molecules can be encapsulated and subsequently released when needed.  
Their surface can, furthermore, be modified to achieve specific binding to target molecules, 
e.g. DNA, proteins, and antibodies. 
Part of the study was, therefore, the synthesis of Ru(bpy)3
2+
-encapsulating liposomes and their 
integration into a DNA hybridization assay.  Subsequently, the development of an assay 
protocol is required which enables the detection of a target DNA linked to a liposome via 
release of Ru(bpy)3
2+
 molecules trapped inside the liposome.  
 
The aim of this research was the identification of signal enhancing strategies for ECL to make 
an incorporation into a microfluidic system lucrative, as well as the investigation of biological 
parameters for a working assay to achieve ECL detection on chip. 
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Fig. 1 ECL Process  
A ECL reagent (e.g. Ru(bpy)3
2+
, luminol, QD) is being oxidized at an 
electrode.  The oxidized species can undergo transfer into an exited, photon 
emitting state.  A coreactant can participate in and facilitate the electron 
transfer processes into the ECL reagent’s excited state and allow for a 
constant applied potential. 
2. Introduction 
2.1 Electrochemiluminescence (ECL) 
2.1.1 Mechanism of Electrochemiluminescence (ECL) 
Electrochemiluminescence (ECL) is an electrochemical process in which molecules undergo 
electron-transfer reactions at an electrode surfaces to form an excited, photon emitting state 
(see Fig. 1).  Thus, the 
emitted light is detected 
upon ECL reaction at the 
introduction of a required 
voltage.  Highly sensitive 
photon detection is 
possible, due to a number 
of existing high 
performance detectors 
and ongoing development 
of more sensitive and 
smaller sensor systems.  
This has led to the 
development of light 
emission reactions into 
highly sensitive analytical 
methods and tools[2].  While fluorescence remains the predominant light-emission-based 
detection method, ECL offers great advantages over fluorescence, which are due to the 
mechanism by which the excited state is generated.  While fluorescence requires an external 
light source, none is needed for ECL.  Light scattering, and thus, importantly, the background 
signal, is reduced.  Thus the virtually background-free detection of ECL can reach higher 
signal-to-noise ratios and lower limits of detection.  Besides, ECL is a highly localized and 
time-triggered detection method, since ECL signal generating reactions will only take place at 
the electrode for the duration of an applied potential.  
Throughout literature, the most common ECL reagents are Ru(bpy)3
2+
 and luminol, though 
many others are known, and more complete lists can be found, for example in reviews by 
Richter[3] and Miao[4].  In recent years, quantum dots (QDs) have also been  studied as ECL 
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reagents[5].  ECL of Ru(bpy)3
2+
 can be generated through an annihilation process, requiring 
only Ru(bpy)3
2+
 in an electrolyte solution [3, 4, 6].  More common, however, a coreactant, 
such as Tripropylamine (TPA), is present during the ECL process, facilitating the generation 
of the light-emitting excited state of Ru(bpy)3
2+
 and allowing for a constantly applied voltage.  
Ru(bpy)3
2+
 coreactant ECL can occur in aqueous solution, making it usable for a large variety 
of biological and medical applications and diagnostics.  
ECL’s main characteristics and advantages are its utility for biological assays; its high 
sensitivity and specificity; and its minimal hardware requirements (i.e. electrodes, voltage 
source and light sensor, all of which can be miniaturized).  This makes it an ideal analytical 
detection method for integration into microfluidic systems.  Microfluidic Total Analysis 
Systems (microTAS) integrate complex sample processing steps specific to the application, 
such as sample incubation, mixing and detection, on a micrometer scale with small sample 
volumes.  In recent decades, microTAS have been increasingly used for biological and 
clinical research and applications[7–12].  However, most microscale ECL systems are not 
microTAS, but microfluidic systems with integrated ECL detection.   
 
2.1.2 Strategies towards ECL Enhancement 
ECL as a detection method has the particular advantage of being a no-background technique, 
resulting in high sensitivity levels and high time and space resolution of the signal.  To 
increase the limit of detection for ECL systems means to increase the number of photons 
emitted from the ECL system during the assay time.  Since only the excited state of the ECL 
reagent is emitting the photons, two general signal enhancement approaches can be taken: (1) 
to increase the number of ECL molecules in the excited state during detection (through 
chemical environment, electrode modification or ECL reagent alternatives), or (2) to increase 
the number of ECL molecules capable of reaching the excited state (through multiplication 
effects in solution and on the electrode surface) (Fig. 2).  The first can be accomplished by 
employing new ECL reagents with higher quantum yields or modifications of the chemical 
environment, or electrodes facilitating the ECL reagent oxidation.  The second one can be 
achieved by an accumulation of ECL reagents via another molecule bearing multiple binding 
sites.  The latter will act as linker between the analyte and the now-multiplied ECL molecules.  
Both strategies have shown great potential throughout the literature to increase the sensitivity 
of ECL detection.  
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Fig. 2 Signal Enhancement Strategies for ECL 
The ECL signal can be enhanced through multiple approaches, mainly falling into one of the following 
categories: manipulation of the ECL system’s chemical environment; changes in the electrodes; introduction 
of a new ECL reagent; or using a molecule capable of binding multiple ECL molecules and thereby creating a 
multiplication effect.  
 
 
 
ECL Signal Enhancement: Chemical Environment for Ru(bpy)3
2+ 
 
Increasing the number of emitted photons for the Ru(bpy)3
2+
 complex means either increasing 
the number of molecules reaching the excited state, or the probability for a single molecule to 
reach the excited state.  Adding a coreactant to the Ru(bpy)3
2+
 complex-containing solution is 
a well-known strategy to increase the complex’s ECL signal.  The classical coreactant used is 
Tripropylamine (TPA).  But others have been investigated and found to lead to even higher 
ECL signals than TPA.  A prime example is DBAE[13].  Han et al. investigated multiple 
coreactants such as monoamines, e.g. 2-(dibutylamino)ethanol and N-butyldiethanolamine 
and diamines including N,N,N’,N’-tetrakis-(2-hydroxyethyl)-ethylenediamine and 
N,N,N’,N’-tetrakis-(2-hydroxypropyl)ethlenediamine[14].  The monoamines led to higher 
ECL signals than the diamines with N-Butyldiethanolamine, leading to the highest so far 
published signal increase for Ru(bpy)3
2+
 from the compared systems and also in comparison 
with the already published system of TPA and DBAE.  DBAE has found increasing use in 
ECL applications[15–35].  It is used as coreactant, not only for Ru(bpy)3
2+ 
but also for  its 
derivatives or for quantum dots, partly applied in quenching techniques.  To our knowledge, 
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Fig. 3 Surfactant arrangement on a gold electrode and its hydrophobic effect.   
Through rendering the surface more hydrophobic but the alignment of surfactant 
(blue)  the coreactant (shown in orange) can reach the electrode easier and more 
coreactant molecules undergo electron transfer. 
Fig. 4 Proposed influence of surface hydrophobicity on ECL signal 
for different electrode materials  
For Au and Pt electrodes (a and b) the ECL signal of Ru(bpy)3
2+
 
with TPA is increased on hydrophobic surfaces, whereas the 
opposite effect is observed on glassy carbon electrodes (c). 
however, only the publication by Han employed N-butyldiethanolamine, which is even more 
promising than DBAE in terms of detected Ru(bpy)3
2+ 
ECL signal.  
Surfactants are known to increase the ECL signal for Ru(bpy)3
2+
 with TPA, as show by 
Workman and 
Richter[36].  The 
authors showed an 
8-fold increase in 
ECL efficiency in 
the presence of 
Triton X-100.  It is 
assumed that the 
surfactant renders 
gold and platinum 
electrode surfaces 
more hydrophobic, 
allowing more 
TPA molecules to 
reach the electrode 
surfaces to be oxidized (Fig. 3).  Through the larger number of oxidized TPA molecules, more 
reacting Ru(bpy)3
2+
 can reach 
the excited state and emit a 
photon.  The most commonly 
used surfactant is Triton X-100.  
In 2004, Li et al. introduced 
Zonyl FSN, a nonionic 
fluorosurfactant, as an alternate 
surfactant capable of ECL 
signal increase with a higher 
yield than Triton X-100[37]. 
Their publication shows an 
about fifty-fold increase in ECL 
signal by using Zonyl FSN 
instead of Triton X-100 for a 
Ru(bpy)3
2+
/TPA system on gold 
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electrodes.  Furthermore, they found a low oxidation potential, attributed to TPA oxidation 
below 1 V.    
Whereas the ECL signal of the Ru(bpy)3
2+
/TPA system on gold and platinum electrodes can 
be enhanced by the addition of Triton X-100, this is not the case for glassy carbon electrodes 
(GC) [38], leading to the conclusion, as shown in other publications, that coreactant-based 
ECL is highly dependent on the electrode material[37, 39–41] (Fig. 4).   
The increase in hydrophobicity that leads to the significantly increased ECL signal on gold 
and platinum can be observed by adding the surfactant to the buffer solution, but also by 
directly rendering the surface hydrophobic.  Bard and colleagues showed that hydrophobic 
thiolated gold and platinum electrodes facilitated TPA oxidation and therewith enhanced the 
ECL signal of the Ru(bpy)3
2+
/TPA system[38].   
 
ECL Signal Enhancement: Novel ECL Reagent Research 
In the search for novel ECL reagents with higher ECL intensity or different ECL properties, 
e.g. emission wavelength, a variety of alternatives to Ru(bpy)3
2+
 have been investigated, such 
as metal–saline complexes[42], which showed ECL activity in acetonitrile solutions, though 
with lower intensity than Ru(bpy)3
2+
.  An interesting finding was reached by Zhou et al. 
during their study of Ru(bpy)3
2+
 and several of its derivatives: one of the most efficient 
luminophores under photoexcitation, the ethoxycarbonyl-substituted derivative, [Ru(bpy-
COOEt)3]
2+
, did not display an intense ECL signal, but, on the other hand, luminophores with 
lower photoluminescence quantum yields showed higher ECL intensity[43]. This shows that 
no direct conclusion can be drawn from spectroscopic data to an ECL emission yield.  In 
search of blue-emitting ECL reagents, thienyltriazoles were investigated[44].  The blue 
emission would be advantageous to broaden the detection range of ECL reagents, especially 
for multianalyte detection strategies.  Superradiant organic dye J-aggregates were investigated 
for their ECL properties with DBAE, as coreactant immobilized on glassy carbon 
electrodes[45], and also on pyrolyzed photoresist film (PPF)-based carbon optically 
transparent carbonelectrodes (COTEs)[25].  These papers demonstrated a proof of principle 
for this new class of ECL molecules, but a comparison with conventional ECL systems would 
need to be done to reveal the extent of actual signal enhancement.  Iridium complexes and 
their ECL characteristics have been studied as well[46]: for example, water soluble 
cyclometalated iridium(III) complexes with disulfonated bathophenanthroline undergo ECL 
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processes, but their intensity has been found to be less than for the Ru(bpy)3
2+
/TPA reference 
system[47].  By investigating ruthenium polypyridyl complexes containing 5-aryltetrazolate 
ligands[48], it was even found that one complex, Ru(4-TBN)Ru
2+
, displays a higher ECL 
efficiency than Ru(bpy)3
2+
. 
Quantum dots are semiconductor nanocrystals that are tunable in size and physical 
characteristics, and are capable of ECL, as first shown by Bard’s group in 2002[49] and 
shortly thereafter[50, 51].  ECL of QDs can be coreactant-assisted or not, with H2O2, K2S2O8, 
TPA and DBAE being some of the most common coreactants.  In addition to direct 
quantitative analytical methods, which rely on ECL signal increase with increased analyte 
concentration, the use of quenching reagents and effects is common in QD ECL applications. 
Quenching can occur through either the analyte itself, interactions with the coreactant, or 
interactions with the ECL pathway products, and has been used in a variety of assays[52–59].  
Bioanalytical applications using QD ECL are most often found in immunoassays[55, 60–66], 
but have also been published, for example, for aptasensor development[67, 68], detection of 
DNA[69, 70], cancer cells[69, 71, 72], ATP[67, 73] or Dopamine[74].  Research, however, is 
not limited to analytical applications for medical or biological assays.  Research about new 
ECL QDs[56, 72, 75], Near-infrared ECL[76–79] or sensing techniques[57, 80] for example, 
is being conducted.  Use of QD films[81, 82], QD-on-electrode systems with ITO 
electrodes[74, 82], bipolar electrodes carbon nanotube modified glass carbon electrodes [83] 
and their characterization has been shown as well. 
Comparing the ECL efficiency of QDs with the classical Ru(bpy)3
2+
 system is not carefully 
done in literature, making thus a direct comparison statement here difficult.  The advantages 
of QDs lie in their tunability and in areas such as Near-infrared ECL, which cannot be done 
with Ru(bpy)3
2+
 due to the emitted wavelength.  Also, QDs display a better capability for 
applications on ITO electrodes.  However, their disadvantages are related to their synthesis, 
which is performed in organic solvents and caps of hydrophobic ligands, which requires a 
surface functionalization prior to biosensing applications, making the preparation more 
expensive and time-consuming than the commercially cheaply available Ru(bpy)3
2+
.  A fair 
comparison of QDs and organic ECL reagents is needed though.  
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2.1.3 Low Oxidation Potential ECL 
The voltage required to initiate Ru(bpy)3
2+
 ECL is typically 1.2 V vs. Ag/AgCl reference 
electrodes: a high voltage, close to the potential of water electrolysis which is -1.23 V at 25°C 
at pH 0.  This can cause bubbling of the solution.  And while disc or macro electrodes are 
stable against such high potentials, can it become a challenge for thin microfabricated 
electrodes, especially when combined with a high currents and gas formation in solution.  
Electrode damage, for example due to electrode fouling and detachment of the electrode from 
its substrate, can occur.  Furthermore, it might interfere with DNA stability, as 
oligonucleotide sequences could get damaged at +1.0 V vs. SCE[84, 85]. 
An approach to overcome this issue could be the use of low oxidation potential (LOP) ECL.  
However, LOP ECL has not been applied to microfluidic systems yet.  It is only on a few 
occasions that LOP ECL is even described in greater detail in the literature. 
The existence of a LOP ECL signal for Ru(bpy)3
2+
 with TPA and the nonionic 
fluorosurfactant Zonyl FSN was demonstrated by Li et al. in 2004[37].  The explanation for 
the low oxidation potential at gold and platinum electrodes was based on the hydrophobic 
condition on the electrode surface and, most importantly, the inhibiting effect on oxide layer 
growth on the electrodes, facilitating the direct oxidation of TPA.  The same group published 
a second paper characterizing the LOP of the Ru(bpy)3
2+
/TPA system in greater detail on gold 
electrodes in the presence of Zonyl FSN-100[39].  In the search for coreactants leading to a 
higher LOP ECL signal, multiple tertiary amine coreactants for Ru(bpy)3
2+
 were compared to 
the most common coreactant, TPA, in terms of their LOP ECL capability[86].  Tri-n-
ethylamine (TEtA), TPA, and tri-n-butylamine (TBuA) were investigated at a Zonyl-FSO-
100-modified gold electrode.  Changes to the electrode hydrophobicity showed that more 
hydrophobic surfaces increased the LOP ECL signal.   
LOP ECL is also possible without the addition of actual surfactants.  Jiang et al.[87] showed 
the existence of a LOP for the Ru(bpy)3
2+
/TPA ECL system at gold electrodes while 
introducing pyridine and its analogues, quinoline and 4,4’-dipyridine, to the system.  The 
proposed assumption was that pyridine and its analogues in fact acted as surfactants, and 
therefore facilitated direct TPA oxidation.   
LOP ECL, however, is not limited to the Ru(bpy)3
2+
/TPA system.  For ECL quantum dot 
(QD) applications, Zou et al.[88] showed that, at low oxidation potentials on glass carbon 
electrodes, anodic near-infrared (NIR) ECL from CdTe QDs could be achieved.  Furthermore, 
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a strategy for greatly enhanced band-gap NIR ECL at low oxidation potential with the dual-
stabilizer-capped CdTe QDs was presented.  The CdTe QDs were used as ECL emitters, 
while TPA was employed as coreactant, leading to two distinct ECL processes at 0.63 and 
0.88 V.  The two identified ECL potentials are much lower than for other reported NIR-
emitting QDs[75, 89] and visible-emitting QDs[90, 91]. 
The ECL signal produced at the low oxidation potential can furthermore be used to measure 
quenching, as the quenching effects on the ECL pathway of Ru(bpy)3
2+
 with TPA can be 
more significantly and sensitively observed under LOP ECL conditions. This phenomenon 
and detection approach was, for example, shown for detection of oxygen[92], uric acid[93] 
and phenolic compounds[94]. 
 
2.1.4 Alternative Detection Methods: Fluorescence and Electrochemical  
Fluorescence 
Fluorescence is a form of luminescence, just as ECL.  However in the case of fluorescence, 
light is emitted upon excitation of the fluorescent substance with absorbed light or other 
electromagnetic radiation.  In particular, an orbital electron of the fluorophore is brought to an 
excited singlet state upon energy transfer from the external radiation.  A photon is then 
emitted when the excited electron falls back to the ground state.  The energy of the emitted 
photon is usually less than the energy of the excitation photon and can be given by the 
Planck–Einstein relation: 
               (1) 
E = Energy of the photon 
h = Planck constant, h ≈ 6.6×10−34 J⋅s  
ν = frequency of the photon 
Meaning that, when the emitted photon has less energy, its wavelength is red-shifted, since 
the frequency ν is correlated to the wavelength λ and the speed of light c by:  
        
 
 
     (2) 
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This phenomenon is called the Stokes shift.  The reason for the shorter wavelength and 
corresponding lower energy of the emitted photon can be, for example, a non-radiative 
relaxation, but can also be caused while interacting with a quencher, a molecule to which the 
energy is transferred, but where the relaxation to the ground state is not accompanied by 
photon emission. 
 
Fluorescence detection is common and frequently incorporated into biological and clinical 
applications on the macro as well as micro scale.  Fluorescence benefits from a wide variety 
of fluorophores that cover the whole visible range while displaying high quantum yields.  The 
quantum yield (Φ) refers to the ratio between of emitted photons to absorbed photons and 
gives a measure for the efficiency of the fluorescence process of the fluorophore: 
        
                          
                           
   (3) 
The widespread use of fluorescence in cell and molecular biology assays is furthermore based 
on the introduction of florescent proteins, which can be directly integrated into, for example, 
cellular structures, where they function as reporter molecules.   
This choice of different fluorescent markers is definitely an advantage of fluorescence upon 
ECL detection.  Even though numerous ECL reagents are known[3], only two of them are 
usually used for commercial applications: luminol and Ru(bpy)3
2+
.  Another limiting factor 
for ECL, compared to other luminescence techniques, is the typically lower efficiency of 
ECL[95].  The main reason is the suboptimal stability of the electrogenerated species that 
undergo transfer into the excited, photon emitting, state of the ECL molecule[95]. But the 
efficiency can be enhanced, e.g. by the use of a coreactant, which makes research to obtain 
better ECL conditions in terms of higher photon yields so essential.  
ECL has many ather advantages over fluorescence which make it ideal for incorporation into 
microfluidic devices.  From a detection standpoint, is it easier to reach lower limits of 
detection with ECL than with fluorescence.  This is due to the requirements for both 
techniques.  While fluorescence requires a light source, light scattering and autofluorescence 
can cause high background levels, and it is a common to invest in strategies to lower the 
background level to increase the signal to noise ratio.  ECL is not faced with this problem, as 
light is only emitted upon introduction of the right voltage.  This correlates with higher 
specificity, since usually only one ECL species is present.  How much lower the limits of 
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detection (LOD) can be is shown by a comparison published by Yuan et al. in 2014[96].  
They compared the sensitivity of their ECL aptasensor with published values of other sensors 
for the same model analyte but different detection technique.  The publications showed the 
LOD reached with fluorescence at 2.48 nM[97] and 0.05 nM[98], with CL at 74.4 pM[99] but 
as low as 10 fM with ECL. 
Another important advantage ECL has over fluorescence for microfuidic sensors is the ease in 
miniaturization of the hardware requirements.  Basically, the only requirements are a voltage 
source and a light detector.  The voltage source can be as easy and cheap as a battery. 
Considering all factors, ECL is a promising alternative to fluorescence and for incorporation 
into microfludic sensors.  The biggest challenge ECL needs to overcome is identifying 
conditions under which higher signals can be achieved.  
 
Electrochemistry 
Electrochemistry deals with the interconversion of chemical and electrical energy, and the 
relation of electricity to chemical changes in a substance.  Electron transfers can occur at an 
electrode interacting with electrolytes and can be measured.  In electrochemical (EC) 
detection, as it is used in sensor applications, usually the analyte itself is a molecule that can 
undergo detectable electron transfer reactions at an electrode, or the analyte is linked to a 
molecule that does.  Often, either a constant potential or a swept potential is applied to the 
system, and the current, resulting from the electrons that are transferred from and to the 
electrodes, is measured.  Cyclic voltammetry (CV) is an example of a sweep voltammetry 
technique.  A potential is applied and swept from a starting value to an end value and back, so 
that a “circle” in potential is introduced to the system.  This technique can help identify, for 
example, the oxidation and reduction potentials of the analyte.   
As for ECL, the mechanism relies on chemical changes of the molecule while interacting with 
electric energy introduced at an electrode.  However, while photons are detected by ECL, 
electrons are detected by EC.  The advantage is, that EC is a highly sensitive technique.  The 
disadvantage is the high background caused by other reagents in solution.  Usually, not just 
one EC capable species is present in solution, but, especially in biological applications, ions 
from buffers and the analyte itself.  So multiple molecules will participate in electron transfer 
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reactions and increase the signal, even if not from the molecule of interest.  ECL, therefore, 
can bring an increase in sensitivity and specificity compared to EC detection. 
 
2.2 Microfluidic Devices  
2.2.1 Microfluidics 
Microfluidics refers to the science of describing and dealing with the behavior of fluids at 
small volumes, typically in the range of microliters and lower, and the manufacturing, design 
and manipulation of the devices containing the liquid in channels ranging from millimeters to 
micrometers in their dimensions.  Microfluidics presents itself as a separate research field, as 
different effects than on the macro scale can become dominant.  The larger ratio of surface 
area to volume, and corresponding increase in surface tension and fluid resistance, plays an 
important role.  One further factor to consider is the fluid flow itself, and how this affects 
mixing if multiple liquids are injected into one device.  The flow at such small scales becomes 
laminar instead of turbulent.  This can be quantified by the Reynolds number (Re), given by 
the ratio of inertial forces (ρvL) to viscous forces (µ). 
     
                
               
  
        
         
    (4) 
 
 
      
      
 
 
   
 
 
 
Re = Reynolds Number (non-dimensional) 
ρ = density (kg/m3) 
v = velocity based on the actual cross section area of the channel (m/s) 
μ = dynamic viscosity (Ns/m2) 
L = characteristic length (m) 
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With the kinematic viscosity ν giving the ration between the dynamic viscosity μ to the 
density of the fluid ρ: 
          
 
 
     (5) 
The Reynolds Number Re can be given by: 
         
  
 
     (6) 
v = kinematic viscosity (m
2
/s) 
 
For laminar flow, the value of Re is below 2300.  When Re is above 4000, the flow is 
turbulent, while in between 2300 and 4000, both laminar and turbulent flow are possible, 
which is referred to as transition flow.  However, Re depends on the channel geometry.  
Practical implications are, for example, the mixing of two liquids.  At low Re values, where 
the flow is laminar flow, the mixing is caused mainly by diffusion.   
 
When designing microfluidic channels, the parameters resulting in the chips’ performance are 
important.  For example, the sample volume needs to be adequate to the volume the channels 
can process, in order to not dilute the analyte or extend the analysis time.  Smaller sample 
volumes than used in bench-top devices correlate with smaller analyte amounts, if no other 
measures are taken to enhance the amount of analyte or signaling molecules.  In general the 
relationship between analyte concentration (c) and sample volume (V) can be given by[100]: 
                                                                                        
 
     
    (7)
     
NA = Avogadro’s number 
ηs = sensor efficiency, 
V = sample volume 
c = analyte concentration 
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2.2.2 Definition and Advantages of Microfluidic Devices and microfluidic Total Analysis 
Systems 
Microfluidic Total Analysis Systems (µTAS), or sometimes called lab-on-a-chip (LOC), are 
devices that perform a whole laboratory process, conventionally conducted with bench top 
tools, starting from sample preparation and treatment to detection, on a nm to cm scale.  
µTAS are usually based on microfluidic processes, to achieve goals such as sample transport.  
However, so called microfluidic chips should not be confused with µTAS.  µTAS refer only 
to devices in which all required sequences of an assay are executed on the chip itself,  while 
microfluidic devices commonly transfer only parts of an assay to its small scale, e.g. mixing 
or detection. 
The advantages of both µTAS and microfluidic chips are numerous, and can be perhaps 
summed up in three words: faster, smaller, cheaper.  Obviously, due to the sheer dimensions 
of microscale systems, only a small sample volume, in the nL to mL range, is required.  This 
is essential in applications where low sample quantities are available for processing or are 
desirable to minimize costs, as for example the case in DNA related applications or blood 
analysis.  The costs are not only minimized due to the lower use of expensive analytes, but 
also due to the relatively cheap manufacturing costs for microfluidic systems based on the 
chip material.  The commonly used substrates such as Polydimethylsiloxane (PDMS), 
Poly(methyl methacrylate) (PMMA), glass, and even paper, are relatively cheap in production 
and manipulation costs compared to the requirements for bench top devices.   
The µTAS and microfluidic dimensions also correlate to faster analysis times and the ability 
for high throughput analysis, as multiple analytical steps can be run simultaneously on one 
device.  The small size correlates with a larger surface area to volume ratio, enabling diffusion 
processes, whole sample heating or cooling, and more processing on a shorter time scale, 
while using less energy than large scale systems.  Faster results and lowered costs are, of 
course, desirable for every application, especially for health-related tests in hospitals or in the 
field.  In fact, chips are ideal for in-field applications: they are small, portable, and aim for 
ease of use, so that even untrained personnel can operate the device. 
Its disadvantages hinder a wide-spread replacement of existing technology with µTAS.  One 
barrier is the cost and time-consuming development of a novel device.  Even though the 
finished products are generally faster and cheaper per analysis, the development itself requires 
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Fig. 5 Principal of a microTotal Analysis System (microTAS) with all steps integrated on chip 
more labor-intensive steps.  Part of this is caused by physical and chemical effects on µm 
scales, which do not allow for a simple down-scaling of existing protocols.  
Maybe the biggest problem with microfluidic devices is based on one of its greatest 
advantages, the small sample volume.  The reduced analyte concentration leads, obviously, to 
a lower signal, and possibly higher signal-to-noise ratio based on the device itself.  It is 
therefore unrealistic to expect microfluidic device to approach limits of detection (LOD) and 
sensitivities of established bench top devices. 
Microfluidic applications are wide spread throughout scientific applications, ranging from in-
field applications such as the detection of pathogens or heavy metals in water, over clinical 
use for the analysis of blood samples, to lab applications such as PCR and immunoassays.  
 
 
2.2.3 Microfluidic ECL Systems 
ECL shows great potential for miniaturization, due to its few hardware requirements.  Since 
no external light source is required for light emission, but only a power source, 
miniaturization can be done with batteries[101, 102], or even phones[103], and thus easily be 
integrated into a microTAS (Fig. 5).  The electrodes can be fabricated on microscale levels 
with various simple techniques, while light sensors can be integrated into the device via small 
PIN photodiodes.  This, combined with research in microfluidic development, allows for 
microscale, high sensitivity, analytical ECL-devices.  In literature, most microanalytical 
devices employing ECL are not microTAS, but focus on the detection aspects rather than the 
sample preparation components of a microTAS.    
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The most common ECL reagent is Ru(bpy)3
2+ 
[101, 103–110] with or without TPA as 
coreactant.  But other systems, like luminol[111–114], carbon nanodots[101] or carbon 
nanocrystals[106] have also been used.  In order to realize ECL in microfluidic systems, 
different strategies and methods have to be chosen depending on substrate material, channel 
design, and electrode fabrication and material.  The electrodes are most often either produced 
by evaporation of the metal onto the substrate with additional lithography, printed circuit 
board (PCB) technology[113, 114] or by using screen printed electrodes (SPE),[101, 102, 
104–107, 111, 115] with the most common electrode materials being gold, and recently also 
ITO electrodes.  Screen printed electrodes (SPE) are often used in microfluidic paper-based 
analytical devices, µPADs, which have been investigated for analytical purposes over the last 
few years since the first proof of concept demonstration by Whitesides and his group in 
2007[116].  Combining paper based microfluidic systems with ECL detection is a relatively 
young, but promising, research field[117] and has been demonstrated by several groups[101–
105, 107, 112, 118, 119].  The publications about ECL microfluidic devices mostly deal with 
the fabrication and characterization of the device itself[103, 109, 111, 113, 120–122] or for its 
use in biosensing, mainly immunosensor applications[101, 102, 105, 107, 110, 112, 123].  
Currently, it is impossible to find a quantitative comparison between ECL and other detection 
technologies in microfluidic systems (as is possible in bench-top assays), i.e. where the same 
assay has been optimized for ECL and also fluorescence, electrochemical or other detection 
principles.  Comparisons, if any, are typically done through literature citations.  However, all 
ECL-microfluidic publications present highly sensitive detection approaches that demonstrate 
LODs at the lowest concentration ranges shown thus far.  Therefore, ECL- integrated 
microfluidic devices show great potential as analytical tools with increased sensitivity.  
 
Another microfluidic application of ECL is found in the field of capillary electrophoresis (CE) 
and the use of Bipolar Electrodes.  CE is an analytical separation technique.  Ions are 
separated by CE according to their ionic mobility under the influence of an electric field.  
Microchip CE is an attractive variation of CE, due to its high performance, short analysis 
time, smaller sample volume, portability and disposability[124]. 
 
One major challenge in microchip CE development is the detector module.   UV absorption, 
commonly used for CE, lacks sensitivity on the microscale format, due to the short path 
length available for the optical measurement.  Laser-induced fluorescence is likely still the 
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most commonly used detection method, which is also commercially available.  Still, for most 
analytes, the fluorescence efficiency is not sufficient.  ECL CE, though not commonly applied 
yet, could provide the necessary sensitivity, and has already shown appropriately low limits of 
detection for many tested analytes[124].  For example, it was shown that limits of detection 
could be reached in the sub-nM level for proteins labeled with Ru(phen)3
2+ 
with TPA as 
coreactant, in a CE-ECL system with less than 0.5 µL dead volume of the microfluidic ECL 
detection cell[125].  Also for ECL CE, alternative ECL reagents are tested, e.g. using 2-(2-
aminoethyl)-1-methylpyrrolidine (AEMP) as a different ECL label than Ru(bpy)3
2+
 with TPA 
or proline as coreactant, with a limit of detection of 2.7 µM and a signal-to-noise ratio of 
3[126].  As in other ECL research, ITO electrodes have been incorporated into CE-ECL 
systems[124].  Thus, for CE, the use of ECL will open the door for applications with more 
difficult and low-concentration analytes, and render the separation technology even more 
powerful.    
The term bipolar electrode (BPE) describes an electronic conductor which is in contact with 
an ionically conductive phase to which an electric field is applied, and causes, at sufficient 
intensity, faradaic reactions at the bipolar electrode[127].  In other words, the electrode itself 
is not directly in contact with the current supply, and a simple power supply, like a battery, is 
sufficient for experimental use.  This leads to the main advantage of BPE, i.e. their potential is 
easy to control.  This can be especially helpful in microfluidic systems, where the working 
electrode potential can be harder to control than with a conventional three electrode system, 
due to the high electric field and solution resistance[127].  Publications for BPE ECL 
microfluidic devices deal, in general, more with the characterization and fabrication of the 
device itself[120–122, 128–133], with and without demonstration[128, 131, 133] of model 
analytes[120–122, 132], than for its use in biosensing applications[134, 135].  
 
For all microfluidic ECL devices, regardless of their substrate, electrode configuration, or 
model analyte (Table 1), the main advantage over the more common fluorescent detection 
approaches is the lower limit of detection that can be reached.  The lack of background signal 
generally leads to a higher signal-to-noise ratio.  Furthermore, the challenge of even better 
LODs combined with device miniaturization is easier to overcome than for fluorescence or 
EC detection.  All of this makes ECL not only a valuable existing tool, but an analytical 
method that will become more integrated into the rising field of microfluidics for biological 
and clinical applications with the need for sensitive detection in small sample volumes. 
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Table 1:   Analytes detected via ECL or microfluidic ECL.   
Groups of molecules (left column) specific analytes (right column); bolded are those analytes 
that were detected in a microfluidic ECL device. 
Main Groups of Analytes Specific Analyte 
  
Coreactants DBAE[103, 104] 
 l-proline[103] 
 NADH[104] 
 TPA[132] 
 nicotine[136] 
 Hydrogen Peroxide[132] [137] [80] 
Cancer Research Tumor Markers[105] [102] [101] [59] 
 carcinoma antigen 125[112] [138] [66] 
 carcinoembryonic antigens[107] [123] [60] [61] [139] 
 Cancer Cells[71]  [69] [72] 
 tumor necrosis factor-alpha (TNF-R)[65] 
Protein cardiac troponin I [140] 
 human C-reactive protein (CRP)[141] [142] [63] 
 α-fetoprotein (AFP)[143] [123] 
 interleukin-6[110] 
 Thrombin [56] [68] 
 folate receptors [134] 
 human prealbumin (PAB)[55] 
Amino Acids [108] l-proline, l-lysine, l-leucine, l-valine, and l-histidine 
[109] 
 Proline[124] 
 Leucine[144] 
Ions Lead Ions[106] 
 Mercury Ions[106] [145] 
 Fe(CN)6
3- 
[133] 
 cupric cation[53] [76] 
Antigens Legionella antigen[146] 
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 Prostate specific antigen (PSA)[110, 123] [147] 
Antibodies Immunoglobulin G (IgG)[148] [78] 
 Rabit IgG[62] 
DNA[142] [70] [69][149] mutant K-ras gene[52] 
Small Molecules Drugs (Methimazole[83], Gossypol[54]) 
 Dopamine[132] [150] [74] [30] 
 phenylethanolamine A (PA)[64] 
 ATP[118] [67] [73] 
Viruses astrovirus[151] 
 
2.3 Cryptosporidium parvum 
Cryptosporidium parvum (C. parvum) is a waterborne pathogen that causes the intestine-
affecting disease cryptosporidiosis. C. parvum spreads mostly through contact with 
contaminated water.  Between 2004 and 2010, 60.3% of worldwide waterborne protozoan 
outbreak was due to C. parvum.  This infection is often lethal to immunodeficient patients 
suffering from other diseases, such as AIDS, very present in resource limited countries.  But 
children and elderly patients are also at a higher risk of a C. parvum infection.  Outbreaks 
occur more frequently in areas with insufficient water treatment, but even happen in western 
countries as well.  It is, in fact, considered one of the most threatening waterborne pathogenic 
organisms in developed countries.  One of the biggest outbreaks, for example, happened 1993 
in Milwaukee, WI in the United States, when 403,000 people were infected[152].  In this 
particular case, two water treatment plants serving the city had been contaminated, leading to 
the spread of the disease. 
C. parvum is also being investigated for its possible carcinogenic effects[153].  It was shown 
that infected SCID mice are at higher risk of gastro-intestinal or biliary cancer, though it is not 
certain if this is the case for humans, as well[154–156].  One study on patients, however, 
showed a high frequency of cryptosporidiosis in patients with colorectal cancer[153, 157]. 
The prevention of infectious outbreaks is challenged by the resistance of C. parvum towards 
most commonly used water treatment methods, such as chlorination, and by its high 
infectiousness. Even though the actual number of oocysts found in contaminated water is 
often very low, the risk is not lessened by this fact, as a volunteer study showed that as few as 
30 oocysts could cause illness in some people[158].  
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Fig. 6 Liposome Schematic 
Left Figure: Liposomal structure cross section.  The lipid bilayer forms a hollow vesicle. 
Right Figure: Inside the lipid bilayer molecules, e.g. ECL reagents (orange) can be encapsulated in large 
quantities.  The surface of the liposome can be modified, e.g. biotin (yellow), DNA tags (blue) or antibodies 
(green). 
Due to the severe consequences of infection, is it important to develop novel systems that 
offer sensitive results on a fast time scale.  Also, due to its prevalence in developing countries, 
is it important to have portable sensors that are easy to use, even by untrained personnel, and 
cheap in fabrication cost; an ideal application for microfluidic chips. 
 
2.4 Liposomes 
Liposomes are artificial bilipid structures, forming nano/microvessels that encapsulate 
molecules and/or are tagged on their surface with molecules [147, 159–163] (Fig. 6).   
In most bioanalytical ECL applications employing liposomes, the ECL-active species is 
encapsulated inside the liposome. The liposome specifically binds to the analyte, either 
directly or through linker molecules.  
To sense the encapsulant, a detergent is introduced to the system, leading to the lysis of the 
bilipid membrane and the release of ECL reagent into solution.  A large number of molecules 
can be encapsulated inside a liposome (10
5
-10
6
 molecules per liposome), as has been shown 
for fluorescence (e.g. SRB[164–170], carboxyfluorescein[171]) and electrochemical (e.g. 
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potassium ferro/ferrihexacyanide[172]) markers.  Improvements in limits of detection have 
been shown to be around 3 orders of magnitude[168].  Still, this strategy has not really been 
exploited for ECL detection yet.  For example, liposomes were successfully synthesized with 
Ru(bpy)3
2+ 
[141, 143, 146], luminol[173–176] (encapsulating either luminol itself or the co-
reactant hydrogen peroxide), or [bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine ruthenium-
di(N-succinimidylester) bis(hexafluorophosphate)][177], with immunosensing[141, 143, 146, 
178] being the most common application.  However, in the case of the luminol studies, these 
were only employed for electrochemical detection, not for ECL signal generation.  Still, the 
general proof of principle was demonstrated, leading to an LOD of 18 nM for the 
oligonucleotide strand, and a signal-to-noise ratio of almost 12 fold[173]. 
Liposomes provide an additional strategy for enhancing the ECL signal by simply increasing 
the number of Ru(bpy)3
2+
 able to undergo an ECL reaction.  This multiplication of ECL 
molecules can be achieved not only through liposomes, but also by dendrimers or attachment 
to nanoparticles; here, mainly gold nanoparticles have been described[55, 179, 180].   
Dendrimers are highly branched molecules that consist of a central core, a dendritic structure, 
and functional groups on the surface[181, 182].  Other molecules can be linked to the many 
available binding sites on dendrimers, making them ideal for applications such as labeling in 
bioassays or drug delivery in medical and therapeutic applications[183, 184].  By binding 
multiple ECL molecules to one dendrimer, which also binds specifically to the analyte 
molecule, a signal enhancement is achieved, due to the multiple ECL molecules involved.  
For example, in the case of a 5
th
 generation dendrimer, 128 ECL molecules can theoretically 
be bound to the dendritic structure.  In addition, dendrimers were also used for surface 
modification, thus enhancing an ECL reaction.  Namely, it was shown that a glassy carbon 
electrode functionalized with a poly(amidoamine) dendrimer with titanate nanotubes displays 
a higher ECL intensity for luminol than an unmodified glassy carbon electrode[137].  The 
same principle proved vital in an ECL assay on ITO electrodes, using Ru(bpy)3
2+ 
with TPA as 
coreactant, which usually displays a low ECL intensity on ITOs, due to their slow kinetics of 
the electron-transfer process[136]. The described assay uses ITO surfaces modified with 
amine-terminated dendrimers encapsulating Pt and Au nanoparticles.  This system led to an 
ECL signal increase of about 213-fold, in comparison to a bare ITO electrode, while only 
losing about 2 % of transparency over the whole visible region.  
In addition to Ru(bpy)3
2+ 
modified dendrimers[185] also Ir(ppy)3[46], various polypyridyl 
Ru(II) complexes[145, 186], CdSe-ZnSquantum dots[71, 73], CdS-PAMAM/GNPs film[150] 
23 
 
and [Ru(bpy)2(PICH)2]
2+ 
[148]
 
have been used for ECL detection, with similar signal 
enhancement achievements to those described above.  Thus, while these bulky detection 
complexes do interfere with the kinetics of binding reactions, and likely suffer from stearic 
hindrance, the multiplication of ECL signal in one complex has proven to be a successful 
strategy on numerous occasions.
 
 
Liposomes offer the simple benefit of a higher signal multiplication capability compared to 
dendrimers.  While a 5
th
 generation dendrimer can bind a theoretical maximum of 128 ECL 
molecules, an increase in magnitude up to 10
5
-10
6
 molecules can be achieved per liposome. 
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3. Material and Methods 
3.1. Reagents 
Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate, Tripropylamine, N-
Butyldiethanolamine, 2-(Dibutylamino)ethanol, Triton™ X-100 and Zonyl® FSN 
fluorosurfactant were purchased from Sigma Aldrich.  Potassium Phosphate Dibasic, 
Potassium Phosphate Monobasic and Tris were purchased from Fisher.  Potassium phosphate 
monobasic was purchased from EMD and Potassium phosphate dibasic from Fisher. N-
Hydroxysuccinimide (NHS) was purchased from Acros, Cystamine dihydrochloride from MP 
Biomedical, 2-(N-Morpholino)ethanesulfonic acid (MES) from OmniPur.  Gold etchant 
trifluoroacetic acid (TFA) was used from Transene and Microposit S1813 Photo Resist and 
developer MF-321 was used from Shipley. 
DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) and DPPG (1,2-dipalmitoyl-sn-
glycero-3-phospho-(1'-rac-glycerol)) were purchased from Avanti and Cholesterol from 
Calbiochem.  The DNA sequences were ordered from Thermo Fisher Scientific.  Dynabeads 
MyOne T1(magnetic beads with treptavidin) were ordered from Invitrogen. 
Potassium Ferricyanide was purchased from EMD, Potassium Ferrocyanide from 
Mallinckrodt and Sulforhodamine B (Sulforhodamin B sodium salt) from Sigma.  HEPES 
was purchased from Ambesco and Sodium Azide from Mallinckrodt Chemicals. 
 
3.2. Procedures 
3.2.1 Microelectrode Fabrication 
Poly(methyl methacrylate) (PMMA) was placed under UV/ozon exposure (UV oven, Jelight 
Company Inc., UVO-Cleaner, Model#144AX) for 8 minutes before covering the surface with 
a stoichiometric solution of 0.3 M EDC and NHS in 50 mM MES solution at pH 6.0 for 30 
minutes.  Afterwards, the PMMA was rinsed with water, dried with nitrogen and covered with 
0.3 M cysteamine solution in 50 mM sodium carbonate buffer at pH 9.0 by placing the 
solution in between two PMMA pieces and leaving them for three hours in humidified 
containers, then rinsed with water and dried with nitrogen.  Gold evaporation with a thickness 
of 200 nm deposited gold was achieved using a CHA Mark50 evaporator at a deposition rate 
of 0.1 nm s
-1
.  S1813 photoresist was spun onto the evaporated gold surface for 30 s at 3000 
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rpm, with a ramp speed of 500 rpm s
-1
 and baked afterwards for 90 s at 90 °C.  UV exposure 
(ABM Contact Aligner) with a mask was done for 12 s before washing the chip with 
developer MF-321 and gold etchant to reveal working, counter and reference electrodes.  The 
RE was fabricated according to three different methods: electroplating, electroless plating and 
silver evaporation.  For the first two, the RE consisted of gold, and was fabricated in the first 
step at the same time and in the same manner as the WE and CE.  For electroplating, 30 µl of 
a 10 mM Ag(NH3)2OH solution was pipetted onto the gold RE.  A platinum wire and an 
Ag/AgCl electrode were used as external CE and RE, respectively. To electroplate the gold 
with silver, cyclic voltammetry steps were conducted from 300 mV to 500 mV at a scan rate 
of 50 mV/s.  In electroless plating, no electrodes are required.  A 0.1 M silver ammonia 
solution was prepared, to which drops of 10% NaOH were added for precipitation.  By adding 
26% NH4OH and using an automated shaker, the precipitate completely redissolved again.  
Another solution of 0.5 M dextrose was prepared, 0.5 M dextrose and 0.1 M silver ammonia 
were mixed in a ratio of 1:5, and the gold surface was covered with the solution.  After 
waiting several minutes and washing, the gold was covered with silver.  With silver 
evaporation, an additional evaporation step was required with silver after the evaporation of 
PMMA with gold.  The PMMA slide was half-covered with aluminum foil for both 
evaporations, resulting in a slide half covered with gold and silver (without gold underneath). 
In the first electrode design, the WE, CE and RE dimensions were 100 mm × 600 mm, 1200 
mm × 600 mm and 100 mm × 300 mm, respectively.  In the newer design, used for EC and 
ECL detection of C. parvum and the investigation of the influence of chemical environment, 
the working electrode dimensions were 300 µm x 5000 µm, and the counter electrode (CE) 
was 5000 µm x 5000 µm in size, with a distance of 300 µm between both electrodes. 
 
3.2.2 Hot Embossing, Bonding and Chip Preparation 
A copper mask with the microfluidic design was used as stamp for the PMMA.  The PMMA 
piece itself (about 4 by 5 cm
2
 and 2 mm thick) was placed on a blank sheet of copper on the 
hot press (Carver Laminating Hot Press, Fred S. Carver Inc., Summit, NJ) and heated to 85 °C 
for 30 sec. Then the copper plate with the fluidic design was placed on top the PMMA and 
pressed together at 4500 lbs for 3 min.  After 3 minutes, the pressure was released, the copper 
plates with the PMMA turned by 180°, and the pressure reapplied for another 2 min.  Turning 
the plates should eliminate uneven depths in the channel due to an uneven heat distribution on 
the hot press.  The PMMA was then removed from the two copper plates and left to cool 
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down before holes were drilled at the inlets of each channel and the outlet of the main 
channel.  With the channel side up, the PMMA pieces were placed under UV/ozone exposure 
for 10 min, together with plain PMMA pieces for SRB detection, or PMMA slides with 
electrodes for ECL and EC measurements.  For bonding one PMMA piece with channel 
design, a plain or electrode covered PMMA piece were pressed together in the hot press at 65 
°C and 4500 lbs for 3 min. in between two blank copper plates.  Then the plates were turned 
again by 180 °C and pressed for another 2 min., resulting in a sealed microfluidic system, 
with overlapping electrodes, if required.  Into the inlet and outlet holes, tubing was fastened 
with super glue. 
 
 
3.2.3 DNA Hybridization Assay 
 For the formation of the hybridization assay, a Hybridization Buffer was used, consisting of 
50% formamide, 10x SSC, 0.5 % ficoll (w/v), 0.3 M sucrose at a pH of 7.0.  During detection 
on chip, a Running Buffer was used consisting of 20% formamide, 4xSSC, 0.2M sucrose, 
0.2% ficoll (w/v), 0.8% dextran sulfase, and 0.1% sodium citrate at a pH of 7.0.  The Capture 
DNA sequence was: 5'-biotin-AGA TTC GAA GAA CTC TGC GC-3'.  The Target DNA 
sequence: 5'-AAGGACCAGCATCCTTGAGTA CTTTCT C AA  CTG  GAG  CTA  AAG 
TTG CAC GGA AGT AAT CA GCG CAG AGT TCT  TCG  AAT CT AG CTC TAC TGA 
TGG CAA CTG A-3'.  The Reporter Probe was: 5‘-GTG CAA CT T TAG CTC CAG TT-
[cholesterol]-3‘.  The Capture Probe was linked to streptavidin on magnetic beads by washing 
5 µl of magnetic beads with more than 50 µl of water, holding them in place inside an 
eppendorf tube with a magnet, and resuspending them in 3.75 µl of water.  Then 1.25 μl of a 
10 µM Capture Probe were added and incubated for 15 min. in shaker at room temperature.  
The beads were washed once more and resuspended in 3.75 µl water. 
The hybridization assay itself consisted of 2.25 μl Hybridization Buffer, 2 μl Liposome 
solution (with Reporter Probe already attached to it), 1 μl target DNA, and 3.75 μl magnetic 
beads with capture probe solution (freshly prepared), incubated at room temperature for 15 
min in a shaker. 
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3.2.4 Liposome Synthesis 
Buffers required for liposome synthesis were: 10x HEPES buffer, consisting of 0.1 M 
HEPES, 2 M Sodium Chloride, 0.1% (w/v) Sodium Azide, pH adjusted to 7.5 with 4M 
NaOH, and volume brought to 1 liter;  and 2 M Sucrose solution with 1% Sodium Azide. 
Both were mixed with a 1x HSS Buffer, which consisted of 200 ml MQ H2O, 400 ml 2 M 
sucrose solution with 1% sodium azide, and 400 ml 10xHEPES, while the volume was 
brought to 4 liters with MQ H2O. 
The encapsulants were prepared differently.  For the EC/fluorescent liposomes, the 
encapsulant consisted of 200 mM Potassium Ferricyanide, 200 mM Potassium Ferrocyanide, 
and 10 mM SRB.  The required amounts of powder for each final concentration were 
dissolved and vortexed in 5 ml of MQ water and 0.9 ml of 0.2 M HEPES.  After dissolving, 
the solution was increased to 10 ml, and either used immediately or stored in the refrigerator 
overnight for liposome fabrication.  For 5 ml of encapsulant for ECL liposomes, 25 mM 
Ru(bpy)3
2+
, 0.5 ml of 0.2 M HEPES and 0.95 ml of 2 M Sucrose were used. 
The liposome synthesis was started by dissolving 0.030 g DPPC, 0.015 g DPPG and 0.020 g 
cholesterol in 3 ml chloroform and 0.5 ml methanol, and sonicating for 1 min at 42 °C.  50 µl 
of crypto Reporter Probe (with cholesterol, and dissolved in 4:1 Formamide/Methanol) was 
added, and the solution sonicated for 4 min.  Then 2 ml of the respective encapsulant, heated 
to 42 °C, was added, before the flask with the solution was attached to a rotary evaporator, set 
to 42 °C.  The rotation was set to the highest rotation speed, and the pressure was lowered in 
50 mbar/hPa steps down to 380 mbar/hPa.  If too many air bubbles occurred, the pressure was 
increased again, but stayed at or under 600 mbar/hPa for 40 to 60 min.  Then the pressure was 
increased, and the rotation stopped, before the flask was vortexed again to bring liposomes 
that might have fallen out of the solution into the solution again.  Another 2 ml of encapsulant 
at 42 °C was added before the flask was attached to the rotary evaporator again.  The rotation 
was set to maximum, and the pressure was lowered in 50 mbar/hPa steps down to 280 
mbar/hPa and left at this pressure for 20 minutes, before the pressure pump was switched off 
and the rotation set to half speed for another 20 min. 
Next, the liposome mix was inserted into an extruder, consisting of two syringes on each side 
of a filter.  The solution was pushed back and forth for 21 times, first through a 1 µm pore 
size and then 0.4 µm (both filters from Whatman Nucleopore).  After the extrusion, the 
liposome mix was run through a Sephadex G-50 column filled with a 1xHSS solution.  This 
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allowed for separation of the liposomes and free dye.  The isolated liposomes were pipetted 
into a dialysis membrane with 2 mL/cm volume capacity and sealed, before placing them into 
800 ml of 1xHSS solution overnight. 
 
3.3. Data Recording and Analysis 
3.3.1 EC Standard Curves 
EC standard curve data was recorded on chip after washing with water at 10 µl/min for 1 min 
and while 0.1 M KCl solution was applied at the RE channel at a flow rate of 5 µl/min.  
During measurements, the RE channel flow rate of the 0.1 M KCl solution was reduced to 0.8 
µl/min.  The analyte solution, consisting of  Ru(bpy)3
2+
 at various concentrations with a 
coreactant/surfactant mix in 0.1 M PB, was injected at a flow rate of 5 µl/min.  A voltage of 
1.2 V was applied for 180 sec before the current was recorded with a potentiostat CV-50W 
(Basi, West Lafayette, IN, USA).  The chip was then washed with the buffer solution 
(coreactant/surfactant in 0.1 M PB) before the same Ru(bpy)3
2+ 
concentration was applied 
again and the recording repeated.  Each concentration was measured in triplicate before the 
chip was washed, and a higher concentration of Ru(bpy)3
2+
 was measured in triplicate. For the 
standard curve, the values for each concentration were averaged and plotted against the 
concentration with their standard deviation.  
 
3.3.2 ECL and SRB Liposome Recording 
Prior to injection of the hybridization assay, the chip was washed thoroughly with water and 
Running Buffer in all channels at 20 μl/min for several minutes.  For ECL and EC 
measurements, 0.1 M KCl solution in PBS was applied at the reference channel, and 60 mM 
OG solution connected to the OG channel but not injected yet.  The needle of the syringe 
filled with OG solution was only hooked up to the tubing after the OG solution was pumped 
to  the end of the needle and a droplet was clearly visible, to ensure injection without air 
bubbles. The hybridization mixture was drawn into a 10 µl syringe and quickly inserted into 
the inlet tubing.  Then the main tubing was quickly connected to the Running Buffer-filled 
syringe, where solution had been flushed through already, to ensure no air bubble injection. In 
cases of air bubbles inside the tubing, Running Buffer was carefully pushed into the channel 
from the syringe, blocking the second inlet in the second fluidic design. This had to be done 
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with great care in order not to lose hybridization solution.  The magnetic beads were then 
washed towards the magnet, which could be done at a high flow rate of up to 20 μl/min, but 
with great care not to lose beads.  Once the magnetic beads reached the magnet, the flow 
needed to be decreased to less than 0.5 μl/min in the old fluidic design, and 1.5 μl/min in the 
new fluidic design, until all magnetic beads were accumulated over the magnet.  After 
accumulation, 60 mM OG solution in 1xPBS from the OG channel was injected at 0.2 μl/min 
for the old fluidic design, and at 1 μl/min for the new one.  Images of the background and 
signal were taken via the microscope camera.  Once liberation occurred, pictures were taken 
in ten-second intervals at an exposure time of 1 sec and analyzed with ImageJ. 
 
3.3.3 Optimization of Chemical Environment for ECL Enhancement 
A sample volume of 40 µL, containing 250 µM Ru(bpy)3
2+
, one of the coreactants TPA, 
DABE, or NBEA, and one of the surfactants, Triton X-100 or Zonyl FSN in 0.1 M phosphate 
buffer (PB), was used for ECL and EC measurements, to determine the optimal coreactant 
concentration and a direct comparison between optimized systems.  The microfabricated WE 
and CE were used in these experiments, with an Ag wire as reference electrode (RE).  A CV-
50W potentiostat (Basi, West Lafayette, IN, USA) was used to apply 1.2 V to the system for 
30 s.  The ECL signal was recorded via a Leica DM LB microscope (Leica Microsystems, 
Wetzlar, Germany) and a digital CoolSnap CCD camera (Photometrics, Tucson, AZ) which 
was operated by imaging software of Roper Scientific Inc. (Tuscon, AZ).  An image of the 
WE was recorded every two seconds at an exposure time of 1 s.  The images were converted 
to grey scale through ImageJ software, in which the signal intensity was determined.  The 
resulting intensity values were integrated over time and normalized by the area of the 
electrode from which they were obtained, and compared to each other as intensity per unit 
area.  
To compare the surfactant-free solution to the ones containing a surfactant, a 200 nm thick 
gold layer on a glass slide was used as WE.  A Pt wire and Ag wire were used as CE and RE, 
respectively.  ECL signal generation and recording were as previously described for the 
coreactant optimization.  The value for NBAE and DBAE in surfactant free solution was 
normalized in relation to surfactant containing solutions, recorded under the same conditions. 
For the dose-response curve and the low oxidation potential study, a three electrode setup 
consisting of a gold disc WE (diameter of 1.6 mm), a Pt wire CE (diameter of 0.5 mm), and 
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Ag wire RE (diameter of 2 mm) was employed.  All electrodes were purchased from Basi 
(West Lafayette, IN, USA).  An Autolab potentiostat (Metrohm, Herisau, Switzerland) was 
used to apply 1.2 V for 30 s.  The luminescence was recorded via a spectrofluorimeter 
(Aminco Bowman Series 2, (AB2)) in bioluminescence mode with a PMT-voltage of 1000 V, 
and the integrated signal was determined via the AB2 software. 
 
3.3.4 LOP Study 
The concentration of Ru(bpy)3
2+
 was at1 µM, 50 mM for NBEA and DBAE, and  0.05wt% 
for Zonyl FSN, as previously optimized.  Tris and Potassium Phosphate (PB) buffer were 
prepared at a concentration of 0.1 M each.  0.1 M PB was prepared with 0.1 M Potassium 
Phosphate Monobasic and 0.1 M Potassium Phosphate Dibasic to reach pH 7 and Tris by 
dissolving Tris in powdered form at the concentration of 0.1 M and then adjusting the pH to 
8.5 with HCl.   The three-electrode setup consisted of a gold disc WE (diameter of 1.6 mm) a 
Pt wire CE, and Ag/AgCl RE.  An Autolab potentiostat was used to apply 1.2 V for 30 sec.  
The signal itself was recorded via an AB2 PMT, voltage at 1000 V, and the integrated signal 
was determined via AB2 software. 
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4. Results 
4.1. Optimization of Chemical Environment for ECL Enhancement 
The combination of Ru(bpy)3
2+
 with a coreactant such as tripropylamine (TPA) increases the 
ECL signal and allows detection in aqueous solutions under a constant potential, which is 
ideal for biological assays[3, 4, 187].  In coreactant-based ECL (Fig. 7), one of the 
coreactants’ intermediate states upon reduction or oxidation can react with the ECL molecule, 
e.g. to form an excited state.  The underlying mechanism for Ru(bpy)3
2+
 ECL can be either 
direct oxidation, catalytic oxidation, or reactions between the Ru(bpy)3
2+
 molecules and the 
amine cation radicals[13, 36–38, 40, 41, 188–194].  In the case of Ru(bpy)3
2+
, the ECL 
molecule is not consumed, and the process can be repeated.   
 
For TPA, it was demonstrated that the surfactant Triton X-100 enhances the ECL signal[36], 
and an 8-fold increase in ECL efficiency in the presence of Triton X-100 was demonstrated 
by Workman et al.  Surfactants are assumed to render gold and platinum electrode surfaces 
more hydrophobic, allowing more TPA molecules to reach the electrode surfaces, and 
consequently resulting in an increased coreactant oxidation rate[37].  The increased number of 
oxidized TPA molecules leads to a larger number of reacting and excited Ru(bpy)3
2+ 
molecules.  Even though micelle interactions could not be ruled out as cause for changes in 
ECL intensity, the stated and more likely explanation is the change in hydrophobicity of the 
electrode surface[3, 36, 195]  Therefore, for Ru(bpy)3
2+
 ECL, TPA in combination with Triton 
X-100 is typically used in analytical applications, providing lower limits of detection and 
enhancing the sensitivity compared to a surfactant free solution. 
 
Fig. 7 ECL Mechanism 
Ru(bpy)3
2+
 and the coreactant tripropyl amine (TPA) 
undergo electron transfer reactions at an electrode, leading 
to the excited, photon emitting state Ru(bpy)*3
2+
.  
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However, in recent years, coreactants such as 2-(dibutylamino)ethanol (DBAE)[13]
 
and N-
Butyldiethanolamine (NBEA)[14] (Fig. 8) have been shown to enhance the ECL signal of 
Ru(bpy)3
2+
 even more than TPA.  Han et al.[14] investigated multiple coreactants such as 
monoamines, e.g. 2-(dibutylamino)ethanol and N-butyldiethanolamine, and diamines, 
including N,N,N’,N’-tetrakis-(2-hydroxyethyl)-ethylenediamine and N,N,N’,N’-tetrakis-(2-
hydroxypropyl)ethlenediamine.  They found that monoamines lead to higher ECL signals than 
the diamines, with NBEA affording the highest so far published signal increase for 
Ru(bpy)3
2+
.  The higher promotion of the amine oxidation by two hydroxyethyl groups 
instead of one is suggested to cause the increased ECL signal.  It was also shown that the ECL 
process is directly related to the oxidation of NBEA.  All of these studies demonstrate that 
investigations on alternative coreactants are valuable in reaching higher ECL intensities. 
 
 
Furthermore, alternative surfactants have been investigated.  Zonyl FSN was shown to 
provide an approximately fifty-fold increase in ECL signal for Ru(bpy)3
2+
 with TPA 
compared to Triton X-100, supposedly due to an increase in TPA oxidation[37].  Even though 
 
 
Fig. 8 Chemical structures of the coreactants Tripropylamine (TPA),  
2- (Dibutylamino)ethanol (DBAE) and N-Butyldiethanolamine (NBEA) 
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Fig. 9 ECL Signal at the Working Electrode (WE) 
Left: Brightfield image of the gold WE and CE 
Middle: ECL signal for 250 µM Ru(bpy)3
2+
 with 100 mM TPA /0.4 mM Triton X-100   
Right: ECL signal for 250 µM Ru(bpy)3
2+
 with 50 mM N-Butyldiethanolamine / 0.05 wt% Zonyl FSN 
 
it has been demonstrated that DBAE and NBEA increase the ECL signal, no publication 
shows the two coreactants in combination with Triton X-100 or Zonyl FSN for Ru(bpy)3
2+
.  
Also, a comparative study is missing which would help elucidate the mechanisms of the 
complex ECL reactions.  This study therefore investigated the effects of both surfactants, 
Triton X-100 and Zonyl FSN, in combination with the three coreactants, TPA, DBAE and N-
Butyldiethanolamine, on Ru(bpy)3
2+
 ECL.  
Electrochemiluminescence is an attractive analytical detection strategy for the detection of 
analytes, and has been studied extensively.  It has been described previously that the ECL 
signal strongly depends on the coreactant concentration[13, 14].  It has also been found that, 
in addition to the original TPA coreactant, other amines can serve the same purpose. 
However, the mechanisms attributed to the various coreactants are different. Specifically,  it 
was suggested that, for DBAE and NBEA, the direct oxidation of the coreactant is of great 
importance at low Ru(bpy)3
2+
 concentrations, and electrocatalytic oxidation of the coreactant 
by Ru(bpy)3
2+
 at higher Ru(bpy)3
2+
 concentrations[13, 14, 36, 38, 189–192].  This begged the 
question of how surfactants influence the various coreactant-based ECL reactions on gold 
surfaces.  While Workman et al. have previously shown that surfactants increase the ECL 
signal due to an increase in hydrophobicity on the electrode surface and hindering of oxide 
layer formation, thus promoting access of TPA to the electrode, it is not clear that this 
mechanism holds true for other coreactant systems of the Ru(bpy)3
2+
-based ECL reaction[36].  
A direct comparison within the same electrochemical and ECL set-up was necessary. 
Experiments were performed on microfabricated electrodes on PMMA (see Fig. 3), as, 
ultimately, ECL will be used in miniaturized (bio)assays. Since gold-plated PMMA is less 
sturdy than solid gold electrodes, additional knowledge was gained by using the more fragile 
electrode system.   
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Fig. 10 Ru(bpy)3
2+
 ECL intensity vs. coreactant concentration for each of the six coreactant/surfactant 
systems.  
Concentrations used were 250 µM Ru(bpy)3
2+
, 0.4 mM Triton X-100, and 0.05 wt% Zonyl FSN in 0.1 M 
phosphate buffer, at 1.2 V for 30 seconds, measured on a microfabricated gold working and counter electrode, 
with AG wire as reference electrode. Analyses were done in triplicates, and standard deviations are plotted 
here.  
 
Initial studies looked at the Ru(bpy)3
2+
 ECL signal obtained for the combinations of the three 
coreactants, TPA, DBAE and NBEA, with the two surfactants  Triton X-100 and Zonyl FSN, 
at varying coreactant concentrations (see Fig.10, Table 2 and Coreactant Optimization in the 
Supplementary Information).  It was found that DBAE- and NBEA-based ECL require 
significantly less coreactant concentration than TPA-based ECL to reach the optimal ECL 
signal with the respective coreactant.  This has also been shown previously, in cases where 
DBAE was used at 20 mM and NBEA at 15 mM, in contrast to 100 mM for TPA, with the 
goal of replacing the toxic TPA with more environmentally friendly coreactants [13, 14].  
However, in the systems investigated in the present study, the coreactant concentration 
needed to be increased in the presence of both surfactants, compared to the previously 
published concentrations.  Triton X-100 required, in general, less coreactant concentration to 
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Fig. 11 ECL signal dependence on the optimized coreactant/surfactant system for 250 µM Ru(bpy)3
2+
  
ECL signal of 250 µM Ru(bpy)3
2+
 with 30 mM NBEA/0.4 mM Triton X-100, 50 mM NBEA/0.05 wt% Zonyl 
FSN, 25 mM DBAE/0.4 mM Triton X-100, 50 mM DBAE/0.05 wt% Zonyl FSN, 100 mM TPA/0.4 mM 
Triton X-100, 200 mM TPA/0.05 wt% Zonyl FSN, 50 mM NBEA and 50 mM DBAE in 0.1 M phosphate 
buffer.  Voltage of 1.2 for 30 seconds on microfabricated gold WE.  Analyses were done on six replicates and 
standard deviations plotted here. 
 
reach optimal ECL intensity, but also led to a lower ECL signal compared to Zonyl FSN for 
each coreactant.  Specifically, with Zonyl FSN as surfactant, the optimal coreactant 
concentration for DBAE and for NBEA was 50 mM; for TPA, 200 mM.  For Triton X-100, 
the highest ECL signal could be observed at 100 mM TPA, 25 mM DBAE and 30 mM 
NBEA. This is significant, as lower coreactant concentrations lead to overall lower current 
flows and, in turn, higher stability of microfabricated electrodes (see further below).  
A direct comparison between the coreactant surfactant systems with these optimized 
coreactant concentrations revealed that NBEA with Zonyl FSN leads to the highest ECL 
signal (Fig. 11 and Table 2).   
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Also, the signal is stronger than the previously published highest increase by NBEA alone, or 
by TPA with either surfactant[14, 36, 37].  We obtained an ECL signal which shows an 
increase by factor of 1.4 over the previously most effective coreactant  NBEA by itself, and a 
factor of 2.7 over the standard TPA/Triton system.   
This proved that the role NBEA plays in the Ru(bpy)3
2+
 ECL pathway is not diminished by 
the surfactant, but instead enhanced.  On the other hand, as the data indicates, DBAE in the 
presence of any of the two surfactants displayed a lower ECL signal than for DBAE alone.  
This is contradictory to the assumption that the surfactant’s effect is solely to render the 
electrode surface more hydrophobic[3, 36, 37, 86, 195].  An increased hydrophobicity of the 
electrode explains the signal enhancement for the hydrophobic TPA.  Furthermore, it would 
suggest to affect the coreactant DBAE in a lesser manner than TPA, due to the two -CH3 
groups and one -OH group of DBAE compared to the slightly more hydrophobic TPA with 
three -CH3 groups.  NBEA by this argumentation should either be more or similarly repelled 
from the electrode surface and its layer of surfactant as DBAE, leading to a lower number of 
coreactant molecules in close proximity to the electrode to participate in electron transfer 
reactions to support the ECL pathways of Ru(bpy)3
2+
.   
As our data indicate the opposite, we suggest that besides the hydrophobic effect of the 
surfactant other aspect need to be taken into consideration.  Both Triton X-100 and Zonyl 
FSN are present in a concentration above the critical micelle concentration (CMC)[196–198], 
ruling this factor out.  However other factors are important.  For example, amongst others, in 
the ECL cycle itself three major parts can influence the ECL signal.  First (1), the oxidation of 
Ru(bpy)3
2+
 at the electrode, second (2) the formation of Ru(bpy)3
2+
-coreactant couples and 
reduction of Ru(bpy)3
3+
 and third (3) the radiative and nonradiarive relaxation to the ground 
state.  For the first aspect, the oxidation of Ru(bpy)3
2+
, it would indeed appear that the 
hydrophobicity is the most important factor and would enhance the signal with the coreactant 
TPA the most and NBEA the least.  Yet in the second part, the positively charged ruthenium 
complex and the less polar coreactant have to be brought into close proximity to enable an 
electron transfer from the tertiary amine.  NBEA in this case with two OH-groups that have a 
negative partial charge will be able to approach the positively charged Ru(bpy)3
2+
 complex in 
closer proximity.  This effect is smaller for DBAE and even less for TPA.  Hence, in part (2) 
the electron transfer should be promoted just in the opposite order of the coreactants as in part 
(1).  For the third factor, the radiative and nonradiarive relaxation to the ground state, the 
surfactant should play an important role, as the decay from the excited state is promoted by a 
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less polar (i.e. water-free) environment.  Less water in the micelle means less quenching and 
higher light emission.  Zonyl as a polyfluorinated detergent should supply a less water 
containing micelle than Triton X-100 which would then explain the trend for the higher ECL 
signal with Zonyl FSN instead of Triton X-100.   
Since however the ECL signal is affected by all of the mentioned factors and even more 
interactions it is hard to conclude a general assumption.  A likely explanation in our case, is 
that the effects of part (2) and (3) dominate the effect of part (1), leading to the signal 
enhancement for NBEA with Zonyl FSN. 
 
Table 2: Optimal coreactant concentration and ECL signal for different coreactant/surfactant 
systems.  Concentrations used were 250 µM Ru(bpy)3
2+
, 0.4 mM Triton X-100 and 0.05 wt% 
Zonyl, and the coreactant concentration as stated in the first row.  Signal was generated on 
microfabricated gold electrodes.  
 
 
As indicated above, the ECL signal was recorded on microfabricated electrodes on PMMA to 
test for the capability and feasibility of incorporation into a microfluidic ECL detector.  
Microfluidic devices are especially necessary in cases with reduced sample volume, or where 
mobility and easy handling are required.  However, reduction of sample sizes led, in general, 
to a decrease in signal, which needs to be compensated for in order to be compatible with 
large-scale detection devices in terms of sensitivity.  ECL-based detection offers the benefit of 
low background noise, and is therefore highly promising for sensitive microfluidic devices.  
ECL requires the presence of electrodes, and the lifetime of a microfluidic device is mainly 
determined by the stability of its active components, such as the electrodes.  Therefore, it is 
critical to prevent the fouling and delamination of the electrodes (in our case, the evaporated 
gold layer), which is inadvertently caused by excessively high current flow.  Microfabricated 
electrodes from various fabrication batches were used for this study.  Also, new electrodes 
were used for each experiment, so that contamination of surfactants could be avoided.  While 
this leads to high standard deviations, as would be expected[199], the direct comparison of the 
 TPA/Triton TPA/Zonyl DBAE/Triton DBAE/Zonyl NBEA/Triton NBEA/Zonyl 
Optimal Coreactant 
Concentration [mM] 
100 200 25 50 30 50 
ECL Intensity [a.u.] 
integrated over 30 sec 
393 
± 109.4 
447 
± 214.9 
457 
± 69.1 
591 
± 13.6 
816 
± 143.2 
1076 
± 122.8 
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standard TPA/Triton X-100 and the optimal NBEA/Zonyl system showed a significantly 
lower current flow for the NBAE system, i.e. dropping from 91 µA (±27 µA) for  TPA/Triton 
X-100 to 64 µA (±29 µA) for NBEA/Zonyl.   
 
Finally, the NBEA/Zonyl FSN system was compared to the standard TPA/Triton X-100 
Ru(bpy)3
2+
 ECL reaction.  This time, experiments were done using a standard gold disc 
electrode, in order to obtain highly reliable and comparable sets of data, and avoiding batch-
to-batch variations of microfabricated PMMA-coated electrodes. A dose response curve for 
Ru(bpy)3
2+
 showed an improvement in the limit of detection (LOD) by a factor of 250 (Fig. 
12 and Table 3).   
Table 3: Limit of detection for Ru(bpy)3
2+
 with 50 mM NBEA/0.05 wt% Zonyl and 100 mM 
TPA/0.4 mM Triton (n=3). Signals were measured with either phosphate buffer or the 
complete ECL solution (without the ruthenium complex) to calculate the LOD.  
Solution used for background 
noise detection 
LOD – NBEA/Zonyl LOD – TPA/Triton 
Phosphate Buffer  1.6 nM 58.42 nM 
Coreactant/surfactants present in 
phosphate buffer 
2.2 nM 0.59 µM 
 
The LOD for Ru(bpy)3
2+
 with TPA/Triton X-100 was at 0.59 µM, but as low as 2.2 nM 
(3σ/slope) with NBEA/Zonyl FSN.  Interestingly, it was observed that the background noise 
afforded by the ECL solution components (minus the ruthenium complex) is much more 
significant for the TPA/Triton X-100 solution than for the NBEA solution. The increased 
background intensity for TPA has already been discovered by Leland at al.[187] when they 
introduced TPA as a signal enhancing coreactant for Ru(bpy)3
2+
.   
NBEA, on the other hand, does not show this negative effect in our study.  Specifically, the 
background noise leads to an increase (worsening) of the LOD by a factor of 10 for the 
TPA/Triton X-100 system, whereas the LOD for the NBEA/Zonyl FSN system is not changed 
(Table 2).  Moreover, the sensitivity, as calculated by the slope of the linear portion of the 
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Fig. 12 Dose Response Curve for Ru(bpy)3
2+
 with 50 mM NBEA/0.05 wt% Zonyl (●) and 100 mM 
TPA/0.4 mM Triton X-100 (■) in 0.1 M phosphate buffer with 2 mm gold disc WE. Analyses were done in 
triplicate, and standard deviations are plotted here.  
 
dose-response curve, was 3.8*10
7
 M
-1
 for the new system, in comparison to only 8*10
5
 M
-1
 
for the standard condition.   
 
Both the decreased LOD and the increased sensitivity are important features for the 
development of analytical systems based on an ECL reaction.  These findings are not only 
beneficial for future to-be-developed miniaturized ECL (bio)sensors, but also for existing 
assays, since no changes are required on the hardware components of an ECL (bio)sensor, but 
only a change in the chemical environment. 
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4.2. Low Oxidation Potential ECL 
While conducting studies on the influence of Tris buffer on the Ru(bpy)3
2+
 ECL system, we 
found that it displays an ECL signal at potentials well below 1V.  Investigated were solutions 
of 1 µM Ru(bpy)3
2+
 with 50 mM NBEA and 0.05 wt% Zonyl FNS in Tris buffer pH 8.5 at 
various potentials (Fig. 13).  Even at potentials as low as 800 mV, a significant ECL signal 
was detectable.  The LOP ECL signal itself showed that a plateau in LOP ECL signal was 
reached between 880 mV and 910 mV vs. Ag/AgCl, and a potential of 890 mV was 
consequently chosen for subsequent studies.  The LOP occurs at the potential for the direct 
oxidation of NBEA, which was shown to be around 900 mV[13].   
 
Previously, no one had reported an LOP ECL signal with NBEA as coreactant.  Therefore, we 
started with the investigation by comparing the signal to a more commonly used phosphate 
buffer system and changing the pH from a standard 7 to 8.5, which is still usable in biological 
assays.  Furthermore, the influence of the surfactant Zonyl FSN was investigated.  To 
complete the study, we tested DBAE for its LOP ECL capabilities as well, and compared it 
with TPA.  
 
Fig. 13 ECL signal for 1 µM Ru(bpy)3
2+
 with 50 mM NBEA and 0.05 wt% Zonyl FNS in Tris Buffer pH 8.5 
according to applied potential vs. Ag/AgCl.  ECL signal was generated on an Au disc electrode vs. Ag/AgCl, 
and integrated over 30 sec. n=3. 
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Fig. 14 CVs for 1 µM Ru(bpy)3
2+
 with the coreactant NBEA.  Left: PB at pH of 7 (blue) and at a pH.8.5 
(Cyan). Right: Tris buffer at a pH of 7 (Pink), at a pH of 8.5 (red) and at a pH of 8.5 in the absence of 
Zonyl FSN (green).  Recorded at a Scan rate of 10 mV/sec vs. Ag/AgCl. 
When recording the EC data for NBEA in the combinations of PB and Tris Buffer at the pHs 
7 and 8.5, we observed strong peaks in current at well below 1 V for all systems except Tris 
buffer at a pH of 7 (Fig. 14). 
 
Indeed, 1 µM Ru(bpy)3
2+
 with the coreactant NBEA in Tris buffer at a pH of 7 did not lead to 
an LOP ECL signal, as could be expected from the CV data (Fig. 14 and 15).  However, the 
LOP ECL signal for PB was minimal, and much weaker than would be expected from the CV 
data.  This shows that, in ECL studies, EC data can be an indicator for the signal intensity, but 
cannot be directly translated, since too many interactions can occur between the different 
components that lead to electron transfer but do not support the formation of the excited 
photon-emitting state of Ru(bpy)3
2+
. 
Only in Tris buffer, pH 8.5, was a clear LOP ECL signal detectable for NBEA (Fig. 15).  
Interestingly, the same LOP ECL intensity was observed in the presence and absence of the 
surfactant Zonyl FSN.  This suggests that, even though the ECL signal at 1.2 V can be slightly 
increased with Zonyl FSN, a surfactant is neither beneficial nor detrimental to the LOP ECL 
of Ru(bpy)3
2+
 with NBEA.   
TPA shows an LOP signal in PB, but only a slight signal in Tris.  For DBAE, an LOP ECL 
signal was observable under all tested conditions.  Only in Tris, pH 7, was the signal the 
highest for DBAE, albeit with high variations in signal.   
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We can conclude that the LOP ECL signal is not only dependent on the buffer system, but 
also on the pH.  The same proved to be true for the ECL intensity at 1.2 V vs. Ag/AgCl (Fig. 
16).  It is therefore assumed that Tris interferes with the Ru(bpy)3
2+
 ECL pathway and, 
consequently, the enhanced production of the excited state.  However, we could not obtain 
any information in the literature to prove this.  Even though Tris can interfere with metals, 
and has been studied in the presence of metal ions such as Mg
2+
, Ca
2+
, Ba
2+
, Mn
2+
, Co
2+
, Ni
2+
, 
Cu
2+
, Zn
2+
, Cd
2+
, and Pb
2+ 
[200], we are not aware of any studies with Ru(bpy)3
2+
 nor of 
possible influences on ECL generation.  However, it is known that Tris can form complexes 
with transition metal ions[201].  Those complexes are mostly formed through deprotonation 
of one of the OH-groups of Tris[201]. 
 
 
 
Fig. 15 LOP ECL signal for 1 µM Ru(bpy)3
2+
 with the coreactants NBEA (■), DBAE (●) and TPA (▲) and 
the surfactant Zonyl FSN under different buffer conditions.  The investigated buffers were, from left to 
right: Tris buffer pH 8.5 without Zonyl (w/o z.), Tris buffer pH 8.5, Tris buffer pH 7, PB pH 8.5 and PB pH 
7.  ECL signal was recorded on a gold disc electrode at a potential of 890 mV. 
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Not only did NBEA in Tris pH 8.5 display an LOP ECL signal, it also showed the highest 
ECL signal, at 1.2 V vs. Ag/AgCl from the investigated systems (Fig. 16).   
 
While the surfactant appears to be of no importance to the occurrence of LOP ECL, the buffer 
conditions themselves influence the signal intensity significantly.  Specifically, the ECL 
signal with NBEA was enhanced when the buffer system was changed from PB to Tris buffer, 
i.e. the signal increased from a value of 37 (±4) to 87 (±7) at a pH of 8.5 and a voltage of 1.2 
V, and from 2 (±1) to 35 (±4) at the LOP voltage.  Consequently, multiple factors can 
interfere with the LOP ECL signal of Ru(bpy)3
2+
 and defined buffer and pH conditions are 
required. 
Overall, it was determined that the optimal LOP ECL signal of the Ru(bpy)3
2+
/NBEA/Zonyl 
system is 40%   lower than the optimal ECL signal at 1.2 V. However, it is still 2.7 times 
higher than the commonly-used TPA/Triton X-100 system at pH 7 in a phosphate buffer (Fig. 
15 and 16), which thus makes it a viable option for all (bio)assay applications and very 
attractive for miniaturized systems.  
 
 
Fig. 16 LOP ECL signal for 1 µM Ru(bpy)3
2+
 with the coreactants NBEA (■), DBAE (●) and TPA (▲) and 
Zonyl FSN as surfactant under different buffer conditions.  The investigated buffers were, from left to right: 
Tris buffer pH 8.5 without Zonyl (w/o z.), Tris buffer pH 8.5, Tris buffer pH 7, PB pH 8.5 and PB pH 7.  
ECL signal was recorded on a gold disc electrode at a potential of 1.2 V. 
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4.3. Microfluidic ECL device using Liposome-based Amplification for DNA Detection 
Microfluidic chips are highly diverse, and specifically designed and manufactured for the 
required application.  Specifically, in our case, the microfluidic channels needed to overlap 
with a three-electrode system.  Since the chip was intended for DNA detection via lysis of 
liposomes, multiple inlets were required to supply the captured DNA with washing and lysing 
solution.  In addition, the chip had to be reusable after DNA detection.   
 
Microfluidic Design 
For preliminary measurements, a chip design was used that had been previously used in our 
lab for EC applications and had been 
designed by Dr. Nongnoot Wongkaew (Fig. 
17).  The chip used three inlets for each of 
the three channels: a) the main channel, into 
which the analyte was injected; b) the OG 
channel which, after washing via the main 
channel, inserted the liposome-lysing reagent 
Octyl β-D-glucopyranoside (OG); and c) the 
reference channel, which supplied the 
reference electrode with KCl solution. 
As a substrate, PMMA was employed.  There 
is a large variety of substrates one can use for 
the fabrication of microfluidic systems, 
including PDMS, paper, glass, and silicon.  
All have certain advantages and disadvantages, and one needs to pick a substrate carefully 
with these requirements in mind.  In our case, the attachment of conductive parts on a non-
conductive substrate is essential, in combination with an easy method to form microfluidic 
channels into the substrate that is transparent for light.  For PDMS and PMMA, there are 
established methods for attaching metal to them while retaining their transparency.  PDMS, 
however, usually requires the use of a plasma oven to seal it to either glass or PDMS, and can 
be rather soft and easy to bend, increasing the risk of a discontinuous metal layer.  PMMA is 
commercially and cheaply available and, combined with the tools and expertise in our lab, the 
better choice.   
 
Fig. 17 Microfluidic Design  
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Incorporation of the micro channel system into the chip was achieved via hot embossing.  In 
this common method for forming PMMA, a mask carrying the microfluidic design is pressed 
into the heated PMMA, to stamp the pattern into it.  The hot press is also used to bind the 
PMMA piece with the microfluidic channels to the one with the electrodes, forming a sealed 
system.  Usually, PMMA needs to be heated above its glass transition temperature for such 
treatment.  However, a UV/ozone treatment allows manipulation well before the glass 
transition temperature Tg[202, 203].  For both steps, embossing and binding, the parameters, 
such as pressure and temperature, had to be optimized, as well as the conditions for 
UV/Ozone treatment itself. 
 
Electrode Fabrication 
ECL requires electrodes in bench-top devices as well as in microfluidic devices.  The 
electrode system usually employed for ECL, and also EC, is a three electrode system, 
consisting of a working electrode (WE), a counter electrode (CE) and a reference electrode 
(RE).  The ECL signal itself will be generated at the WE, set to the specific voltage required 
for the ECL pathway in relation to the RE.  The different requirements and functions of the 
electrodes are reflected in their material of choice.  For instance, as the analytical reactions 
take place at the WE, the WE material needs to be inert in order to be unaffected by the 
current going through it.  Therefore, gold, platinum, and carbon are often used as WE.  The 
counter, or auxiliary, electrode needs to be made out of an inert material as well.  It is used as 
source and drain for the current, but does not participate in the electrochemical reaction.  The 
current itself flows between the WE and the CE.  The RE is the potential reference to the WE.  
Ideally, it should stay unaffected by current flow passing through it, and hold a constant 
potential.  This can be achieved by either having a high input impedance, reducing the current 
flow, or use of a non-polarizable electrode where a small flow of current does not affect the 
potential.  The classical reference electrodes are, for example, made of Ag/AgCl, saturated 
calomel, or mercury/mercury sulfate. 
In bench-top devices, the realization of a three-electrode system is fairly easy.  Numerous 
companies offer electrodes with known dimensions.  In commercial large-scale ECL 
machines, the electrodes are already incorporated.  In self-built microfluidic devices, 
however, incorporation of a working three-electrode system is a great challenge.  Of course, 
one could think of a system where commercially available macro electrodes can be attached 
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Fig. 18 Surface thiolation schematic of PMMA  
to the chip: e.g., a platinum wire could be inserted into the microfluidic system through a 
drilled and sealed hole.  Considering the price for those electrodes, a few hundred euros 
would be required for a complete system.  Even if the same electrodes can be used while the 
chip is replaced, one is faced with problems, such as possible leaking on the places where the 
electrodes are inserted into the system, lower mobility, and the need for more highly-qualified 
personnel for operation.  For general testing, a macro electrode system is still highly valuable, 
since it eliminates several complex factors, e.g. electrode delamination and flow effect.  But 
for large scale manufacturing, it is not an option that is affordable, fast and easy to use.  For 
autonomous microfluidic ECL systems, it is therefore essential that a three-electrode system is 
incorporated into each chip.   
Specifically, for PMMA, the surface can be thiolated, enabling the linkage of gold to it[172, 
199, 204].  For the 
thiolation (Fig. 18), a UV 
treatment is required to 
induce carboxyl (C(O)OH 
group) formation.  Surface 
thiolation is achieved via 
further treatment with EDC 
(N-(3-
Dimethylaminopropyl-N’-
ethylcarbodyamide-
hydroxychloride)), NHS (N-
Hydroxysuccinimide) and cystamine (C3H7NO2S).   
The gold itself can then be evaporated under clean-room conditions via e-beam evaporation.  
Since gold forms strong bonds with free thiols, no further treatment is required.  A layer of 
designated thickness can be evaporated and used for measurements. 
Gold is therefore a good choice as WE and CE material, which require inert materials.  
However, for the RE, another metal is needed.  For the first Ru(bpy)3
2+
 EC measurements 
with the device, silver was electroplated on a gold RE to form, together with the KCl solution 
in the reference channel, an Ag/AgCl RE.  The initial electrode dimensions were 100 m × 
600 m for the WE, 1200 m × 600 m for the CE, and 100 m × 300 m for the RE (Fig. 
19).  The connecting pads were glued to a copper wire with conductive glue, to allow 
attachment to the potentiostat supplying the required voltage. 
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The microfluidic channels needed to be aligned with the electrodes to close the three-
electrode system and to allow for detection (Fig. 20).  The analyte was inserted via the main 
channel, and detection accured on the WE. 
 
 
Electrochemical (EC) Measurements 
For our first insights into the behavior, handling and limitations of the chip, EC measurements 
were performed with the device as an initial step.  Ru(bpy)3
2+
 is probably the most common 
ECL reagent in literature, and was also used for our assays.  Ru(bpy)3
2+
 ECL is rarely used by 
itself in analytical applications, but in combination with a coreactant and sometimes with a 
surfactant, both intended to increase the ECL signal.  Therefore, as first tests, three 
coreactants, TPA, DBAE and NBAE, were combined with the surfactants Triton X-100 and 
Zonyl FSN.  Under a voltage of 1.2 V, the current on the WE was recorded depending on 
different Ru(bpy)3
2+
 concentrations, from which standard curves of Ru(bpy)3
2+
 under different 
coreactant/surfactant conditions were determined (Table 4 and EC Standard Curves  in the 
Supplementary Information).  
      
 
Fig. 19 Three electrode setup design on chip 
Dimension:  
WE =   100 m × 600 m 
CE  = 1200 m × 600 m 
RE  =   100 m × 300 m  
The connecting pads do not participate in the ECL or EC 
reaction, but offer electric contact to the potentiostat. 
 
 
Fig. 20 Microfluidic Chip 
Schematic drawing of fluidic and electrode 
overlap (top) and finished chip with tubing 
and copper wires (bottom).  
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It was found that, for EC, Zonyl FSN leads to lower limits of detection for every coreactant, 
compared to the more commonly used surfactant Triton X-100.  However, more importantly, 
it revealed weaknesses of the chip itself.  While conducting the measurements for the EC 
comparison and preliminary ECL measurements, it was found that delamination of the gold 
occurred for some chips.  When the ∆E of 1.2 V were applied and ECL solution containing 
the Ru(bpy)3
2+
/coreactant/surfactant mix was 
flown through the channels, it could sometimes be 
observed that the gold of the WE as well as the 
gold of the CE detached from the PMMA (Fig. 
21).  A correlation was observed between the 
current and detachment: when the current reached 
about  2*10
-5
 A, the connection between electrode 
and connection pad failed, and the chip was 
unusable.  It was therefore likely that the WE was too small, and the high voltage and 
resulting current led to the detachment and instability of the electrode system. 
The RE suffered in stability over time as well.  The electroplated silver could be washed away 
over time.  The destruction of the electrodes was a significant problem for reliability and 
reusability of the device.  In addition, the connection of the connecting pads to the potentiostat 
Table 4: EC Detection of Ru(bpy)3
2+
, in different chemical environments 
   
Measured Current Range 
  
Coreactant/Surfactant 
LoD, 
[µM] Sensitivity min, [A] Max, [A] 
Value at 
100 uM, 
[A] 
Value at 
500 uM, 
[A] 
       TPA/Triton X-100 47.2 1.81E-009 -1.76E-07 -1.73E-06 -3.22E-07 -1.09E-06 
DBAE/Triton X-100 68.27 2.01E-08 -2.09E-06 -1.78E-05 -4.29E-06 -1.19E-05 
N-BEA/Triton X-100  33.97 2.98E-08 -1.38E-06 -1.61E-05 -5.18E-06 -1.61E-05 
       TPA/Zonyl FSN 4.68 8.31E-09 -1.97E-07 -4.25E-06 -8.63E-07 -4.25E-06 
DBAE/Zonyl FSN 22.87 8.05E-09 -6.00E-07 -4.52E-06 -1.12E-06 -4.52E-06 
N-BEA/Zonyl FSN 15.51 3.78E-08 -9.47E-07 -1.91E-05 -2.97E-06 -1.91E-05 
 
 
 
Fig. 21 Detachment of gold WE and CE 
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Fig. 22 New three-electrode system 
Left: Schematic drawing of the electrode arrangement. Au WE 
and CE, as well as Ag RE and connecting pads, are increased in 
size.  Right: picture of the three-electrode systems on PMMA. 
via glued copper wires was hard to realize.  Furthermore, it was frequently observed that the 
thin connection from the electrode to the connecting pad broke during bonding of the chip due 
to thermal stress, leaving the electrodes isolated.   
 
Changes in Electrode and Microfluidic Design 
The instability of the WE, due to its size, and the RE, due to its fabrication method, required a 
novel electrode design and, in the case of the RE, a new fabrication approach, both of which 
were accomplished by Dr. Olivier Bolduc, as well as subsequent changes in the fluidic 
pattern.  All electrodes were increased in width to sustain the high current running through 
them when ECL reagents are used.  Specifically, the WE and RE width were increased from 
100 to 300 µm, and the CE from 1200 to 5000 µm.  The channel length, and therefore the 
length of the exposed electrodes, remained the same.  The connection to the connecting pads, 
as well as the connecting pads 
themselves, were redesigned (Fig. 
22).  Multiple and thicker 
connections were used, since it 
increased the chance of one 
connection being intact, even 
when others broke during thermal 
stress.  The connecting pad was 
expanded, and moved towards the 
edge of the PMMA in order to be 
connected to the potentiostat’s 
clamps directly.  This eliminated the vulnerable connection via copper wire that would 
eventually break or loosen from the glue. 
The realization of a silver electrode, without a layer of gold underneath, was accomplished by 
adding a second evaporation step in the clean room fabrication of the chip.  Originally, a 200 
nm thick layer of gold was evaporated onto the whole PMMA slice, revealing the three gold 
electrodes after lithography and etching steps.  In the new approach, however, two metal 
evaporations were conducted, one with gold and one with silver, to receive a gold WE and CE 
and a silver RE.  With the application of a 0.1 M KCl solution in the RE channel in contact 
with the silver RE, an Ag/AgCl RE was realized with the new system as well.  In order not to 
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Fig. 23 Schematic of electrode fabrication with gold WE and CE and silver RE 
A thiolated PMMA sheet (1) is covered on one half with Al foil (2) before gold evaporation (3), allowing only one 
side of the PMMA to be covered with gold (4).  Next, the half of the gold PMMA side is covered with Al foil (5) 
before silver evaporation (6), leading to a PMMA slide which is coated with gold on one half and with silver on 
the other (7).  Photoresist is spun on the metal covered slide and baked (8) before a mask with the electrode design 
is used for UV exposure (9).  Upon washing, the dissolvable photoresist can be washed from the slide, remaining 
only at the places the electrodes should be (10).  With gold etchant, the gold and the silver not covered by 
photoresist can be etched from the PMMA, while with an additional UV exposure of the whole slide, the 
remaining photoresist can be removed in an additional wash step, leading to the final three electrode system (11).  
have the gold and silver layer overlap, which would result in all three electrodes being of the 
same material, it was necessary to cover first one half of the chip and then the other for the 
second evaporation (Fig. 23).  In our case, aluminum foil was used to cover the PMMA.  
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Fig. 24 SRB fluorescence signal pre- liposome lysis inside the microfluidic channels. 
(Left) liposome solution reaches OG channel, which is filled with running buffer. 
(Right) solution in OG channel has been washed out, while liposome solution is still present in the main 
channel (signal on the left side of the channel). 
 
After both evaporations, the PMMA was then covered on one half with a 200 nm layer of Au, 
the other with a 200 nm layer of Ag.  Subsequent lithography via UV exposure through a 
mask and metal etching revealed the three electrodes in two different metals.  This enhanced 
the stability of the RE, and reduced degeneration due to liquid flow and could be observed in 
following measurements.  
 
Beside the electrodes, it was also necessary to change the channel design as well.  The well-
established fluorescent molecule Sulforhodamine B (SRB) was used for first investigations of 
the microfluidic channels.  SRB has maximal absorbance at 565 nm and maximal 
fluorescence emission at 585 nm.  While testing the chip with a hybridization assay with 
magnetic beads and SRB encapsulating liposomes, it became obvious that the fluidics needed 
to be improved.  In the assay (as described in more detail later) the liposomes were coupled to 
an analyte DNA, which itself was attached to magnetic beads to allow fixation in the chip 
(Fig. 27).  It became obvious that, when changing the solution, the change in pressure led to 
the analyte solution moving back towards the inlet of the main channel, but also into the OG 
channel (Fig. 24).  Furthermore, it became difficult to wash the solution in the main channel 
out when the OG solution was applied.  In response to this, a second inlet at the main channel 
was introduced, so that a constant pressure could be applied.  To solve the side flow into the 
OG channel, the connection between them was reduced in size and angled.   
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Fig. 25 Magnetic bead removal on chip. 
Magnetic beads, previously assembled at the 
magnet, are being washed out downstream due to 
too high a flow rate. 
 
Fig. 26 Second microfluidic and electrode design. 
Left: Microfluidic design 
Middle: Microfluidic channels are overlapped with new electrode design. 
Right: Finished chip with tubing and exposed connecting pads on the sides of the PMMA. 
In addition, it was determined that accumulation of the magnetic beads over a magnet placed 
underneath the main channel required a very low flow rate.  Increasing the flow rate to over 
0.5 µl/min in the main channel and 0.2 μl/min 
in the OG channel pushed the magnetic beads 
beyond the magnet and, in most cases, led to a 
complete loss of the magnetic beads, together 
with the analyte.  It was easily observable 
under brightfield conditions (Fig. 25), where 
the edge of the magnet was clearly visible as 
well as the magnetic beads.  As can be seen in 
Fig. 24, a higher flow rate led to a washing out 
of the magnetic beads before detection of the 
analyte was possible.   
As such low flow rates are inefficient for fast assays, as the required assay times was over 40 
minutes, it was necessary to change the diameter of the accumulation zone (Fig. 26).  While 
the diameter in most parts of the main channel was unchanged, the channel was expanded to 
twice its width at the site where the magnet was placed.  This allowed for faster flow rates, as 
the local flow in the accumulation zone was reduced due to the wider channel width.  The 
flow rate could be increased to 1.5 µl/min in the main channel and 1 µl/min in the OG channel 
without the risk of losing the magnetic beads. 
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Fig. 27 Schematic hybridization Assay inside the microfluidic device. 
The target DNA is linked to liposomes and magnetic beads, and held in place by 
a magnet placed underneath the chip and in front of the electrodes. 
Hybridization Assay 
The microfluidic device is intended for pathogen detection in water samples, although the 
device will not be limited to this application.  Any kind of DNA or RNA can be theoretically 
detected with the device if the necessary parameters are adjusted, e.g. the DNA or RNA 
sequences need to be specific for the analyte.  There are numerous options one can choose for 
the detection of DNA in a microfluidic device.  However, it is important that the DNA is 
immobilized so the detection can happen, and, furthermore, that all unbound DNA or 
targeting molecules are removed so as to not lead to a false signal.  One common method to 
immobilize the DNA inside the chip is to attach it directly to the substrate or, as in our case, 
the electrodes.  This method requires a thorough cleaning of the channels if the chip is to be 
used for more than one assay.  A more elegant method to reach reusability is by linking the 
analyte to magnetic beads.  The magnetic beads, and therefore the analyte, can be held in 
place inside the chip with an external magnet till all unbound DNA is washed out.  After the 
specific signal is recorded, the magnet is simply removed, allowing for the bound DNA to be 
washed out.  The chip is therefore easily recyclable.   
For our applications, the DNA should not only be linked to one ECL reagent.  To enhance the 
signal, we chose to employ liposome-encapsulating ECL molecules.  The surface of 
liposomes can be 
modified to link to 
biomolecules (e.g. 
DNA, proteins, and 
biotin).  Therefore, in 
our case, the DNA 
can be linked to the 
magnetic beads for 
immobilization and 
at the same time to 
liposomes for signal 
increase.  Fig. 27 
shows the general 
idea of the assay, in 
which the analyte 
DNA (Target DNA) is linked to Capture DNA, which is attached to magnetic beads (MB) via 
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a biotin-strepdavidin bonding.  The target DNA is linked with a reporter probe DNA that has 
been incorporated into the surface of the liposomes. In our approach, the C. parvum-specific 
DNA sequence is attached to the surface of the liposomes via a cholesterol tag.  Cholesterol is 
one of the lipids of which the bilayer consists.  The lipids themselves are not randomly 
distributed over the sphere, but form clusters of the same kind of lipid (Fig. 28).  A DNA 
linked to a cholesterol-tag and added upon formation of the bilipid structure can then be 
incorporated into the cholesterol cluster, leaving the DNA linked to the liposome, but exposed 
to a complementary DNA strand.  
Inside the liposomes, ECL molecules, as well as fluorescent and EC molecules, were 
encapsulated that would lead to a signal upon release from the lipsomes.  Liposomes are 
vesicles consisting of lipids and can be broken apart by, among other things, the influence of a 
surfactant.  Previous studies revealed that a surfactant with good liposome-lysing capabilities 
is Octyl β-D-glucopyranoside (OG).  When introduced to the immobilized liposomes, after 
the unbound liposomes have been washed out inside the channel, the OG solution destroys the 
tight vesicle structure and the signaling molecules can be detected.  
 
 
 
   
              
Fig. 28 Schematic of lipid arrangement in a bilipid liposome structure. 
The different lipids, such as cholesterol, are not individually distributed over the liposome surface, but 
arrange themselves in patches.  A DNA strand with a cholesterol tag can be stably incorporated into the 
cholesterol patch and connected to other DNA strands. 
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DNA Detection on Chip 
Incorporating Ru(bpy)3
2+
 into liposomes is rarely demonstrated in the literature[141, 143, 
146], and, to our knowledge, has never been incorporated into a microfluidic system.  
Therefore, it was a logical consequence to start with a more established liposome system to 
test the hybridization assay conditions and the chip.  SRB (sulforhodamine B) was used 
frequently in our lab as liposome encapsulant and marker.  Furthermore, fluorescence 
detection offered the advantage of focusing on the microfluidic system and the assay, instead 
of the electrode fabrication that would enhance the complexity and the cost per chip.  A C. 
parvum-specific liposome encapsulating 150 mM SRB was the first kind of liposome with 
which a positive liberation on chip was achieved (Fig. 29), which included tests on the 
hybridization assay and the flow on chip.   
The best results were achieved when the different hybridization components were mixed 
under the following conditions and incubated for 15 min: 
1. 2.25 μl Hybridization Buffer 
2. 2 μl Liposome Solution (with Reporter Probe already attached to it) 
3. 1 μl target DNA  
4. 3.75 μl magnetic bead with capture probe (prepared from 5 μl of magnetic bead 
and 1.25 μl of 10 µM Capture Probe, washed, incubated and resuspended in 3.75 
μl of water) 
Before applying the solution to the chip, a thorough wash step with water and Running Buffer 
was done via filled syringes hooked up to syringe pumps.  Since the total hybridization assay 
volume is only 9 μl, a 10 microliter syringe was used for injection into the inlet tubing of the 
chip.  With running buffer, the hybridization mixture was pushed through the tubing into the 
main channel, where the magnetic beads accumulated over the magnet, placed underneath the 
chip.  After accumulation and washing of the unbound components, 60 mM OG solution in 
1xPBS was inserted, also via syringe pump, leading to the release of SRB and detection in the 
channel downstream of the accumulated magnetic beads.  Through removal of the magnet 
after detection, the chip could be cleaned and reused.  
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After successful DNA detection via SRB encapsulating liposomes, the next step was detection 
via EC reagent encapsulating liposomes.  As EC reagent, 200 mM ferri/ferro hexacyanide was 
used.  Ferri/ferro hexacyanide requires a significantly lower voltage than Ru(bpy)3
2+
, only 400 
mV instead of 1.2 V, and is a well studied EC system.  
This required the fabrication of new liposomes.  Since it was uncertain if the electrochemical 
detection of C. parvum would be successful, liposomes were employed that, besides 200 mM 
ferri/ferro hexacyanide, also contained 10 mM SRB.  This setup allowed for visual 
  
Fig. 29 Liberation of SRB after liposome lysis.  
Left: background before lysis. 
Right: SRB signal inside the microfluidic channel after lysis of liposomes linked to C. parvum DNA with 
OG solution. 
 
Fig. 30 EC detection of C. parvum DNA. 
EC signal (blue) upon lysis of 200 mM ferri/ferro hexacyanide encapsulated liposomes and negative control 
(red). 
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confirmation of liberation with the established SRB.  Experimental condition of fluid injection 
remained the same as for fluorescent detection.  At the WE, an increase in current could be 
observed after liposome lysis.  A clear increase compared to the background signal, as well as 
to a blank (Fig. 30).  The signal increased 20 times compared to the blank when taking the 
area underneath the curve as the value measured, and about an order of magnitude when 
taking the current itself. 
The increase in fluorescent signal could, furthermore, be perfectly matched to an increase in 
current upon lysis (Fig. 31).  
 
For Ru(bpy)3
2+
 encapsulating liposomes, we had to start even with the right encapsulant, since 
information for Ru(bpy)3
2+
 liposomes is lacking. For liposome encapsulants, the right osmotic 
pressure is important, and needs to be adjusted according to the pressure outside of the 
liposomes, given by the surrounding buffer.  It the difference in osmolality between the inside 
and outside of the liposomes is too strong, more than 50 mol/kg, the liposomes are not stable.  
Usually, for stabilization, a mixture of HEPES and sucrose is used.  However, when 
dissolving Ru(bpy)3
2+
 in HEPES solution, a color change occurred.  The solution turned 
 
Fig. 31 EC detection of C. parvum DNA with fluorescent signal by SRB  
200 mM ferri/ferro hexacyanide and 10 mM SRB were encapsulated into liposomes and can be detected at the 
same time 
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Fig. 32 25 mM Ru(bpy)3
2+
 in water (top) 
and HEPES buffer (bottom) 
darker, compared to a dilution in water (Fig. 32).  Since such a color change could indicate a 
complexation of Ru(bpy)3
2+
 and possibly influence the ECL, experiments were required to 
determine such an effect.  Therefore the following solutions were tested: 
a) 250 µM Ru(bpy)3
2+
 in N-Butyldiethanolamine/Triton X-100 Buffer (prepared right 
before the experiment); blue data set in Fig. 33. 
 
b) 250 µM Ru(bpy)3
2+
 in N-Butyldiethanolamine/Triton X-100 Buffer diluted from a 
25 mM Ru(bpy)3
2+
 solution in water; red data set in Fig. 33. 
 
c) 250 µM Ru(bpy)3
2+
 in N-Butyldiethanolamine/Triton X-100 Buffer diluted from a 
25 mM Ru(bpy)3
2+
 solution in water/HEPES mix; green data set in Fig. 33. 
 
Both b) and c) were stored in the refrigerator. For all solutions, a potential of 1.2 V was 
applied, and pictures were taken of the signal at different exposure times to rule out a false 
result by overexposure of the camera.  All solutions were tested three times, while the chip 
was rinsed in between tests with N-Butyldiethanolamine/Triton X-100 Buffer.  Also, the 
signal for plain buffer was recorded to obtain the background signal (purple data set in Fig. 
33).  The EC signal is in the same order for all 
solutions, but more importantly, this was also the 
case for the ECL signal for the different solutions 
(Fig. 33), where the averaged pixel intensity is 
shown for various exposure times.  The data shows 
that there is no negative influence of HEPES on the 
light emission of Ru(bpy)3
2+
.  This holds true even 
when the Ru(bpy)3
2+
 was stored in the HEPES 
solution for a longer period of time.  The liposomes 
could, therefore, be fabricated with the standard 
protocol, using HEPES. 
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The concentration of encapsulant should be as high as possible, and 25 mM Ru(bpy)3
2+ 
were 
still dissolvable and used for liposome fabrication.  For 5 ml of encapsulant, 0.5 ml of 0.2 M 
HEPES and 0.95 ml of 2M Sucrose led to an osmolality of 531 mmol/kg.  The first two 
batches of Ru(bpy)3
2+ 
liposomes were prepared with 10 mM SRB as well, since it had proven 
useful for the EC liposomes to confirm the liberation with the established fluorescent system.  
Unfortunately, even though fluorescent detection was possible, no EC nor ECL signal was 
observable.  The fluorescent detection established that the hybridization assay worked.  
However, not even lysed liposomes themselves led to an ECL signal.  Failure of the electrode 
connection was also ruled out by testing plain Ru(bpy)3
2+
 solutions on the same electrodes 
and obtaining an ECL signal in those cases.  Either the SRB interfered with the Ru(bpy)3
2+
, or 
an encapsulation of Ru(bpy)3
2+
 had not been possible. 
 
Fig. 33 ECL signal of 250 µM Ru(bpy)3
2+
 with N-Butyldiethanolamine/Triton X-100 Buffer in different 
media.   
Blue: 250 µM Ru(bpy)3
2+
 dissolved in N-Butyldiethanolamine/Triton X-100 Buffer. 
Red: 250 µM Ru(bpy)3
2+
 in N-Butyldiethanolamine/Triton X-100 Buffer diluted down from 25 mM 
 Ru(bpy)3
2+
 in water. 
Green: 250 µM Ru(bpy)3
2+
 in N-Butyldiethanolamine/Triton X-100 Buffer diluted down from 25 mM 
 Ru(bpy)3
2+
 in a water/HEPES solution. 
Purple: Background signal of N-Butyldiethanolamine/Triton X-100 Buffer. 
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Fig. 34 ECL detection of C. parvum DNA at ΔEapplied = 1200mV vs. Ag/AgCl. 
1: Assembly of magnetic beads linked to the target DNA and Ru(bpy)3
2+ 
liposomes. 
2: Bright field image of the WE and main channel. 
3: Background signal, when 1.2 V have been applied but lysis has not been initiated. 
4: ECL signal of Ru(bpy)3
2+ 
at the WE upon liposome lysis via 60 mM OG solution with NBEA and Triton 
X-100. 
 
Another attempt was made to fabricating 25 mM Ru(bpy)3
2+  
liposomes, but without SRB 
present.  Indeed, in a plain Ru(bpy)3
2+ 
solution, it was possible to encapsulate Ru(bpy)3
2+ 
inside the liposomes.  In a hybridization assay on chip, it was possible to liberate and detect 
Ru(bpy)3
2+
 at the WE (Fig. 34). 
 
Based on the identification of the right hybridization assay and flow conditions, and with the 
use of the synthesized liposomes, the limits of detection for the various detection techniques 
were investigated in subsequent measurements by Dr. Olivier Bolduc.  For the limits of 
detection for C.parvum, it was found that for SRB the LODFluorescence was 46 nM; for 200 mM 
ferri/ferro hexacyanide encapsulating liposomes (ΔEapplied = 400mV) a LODEC of 9 nM was 
found; and with the use of 250 µM Ru(bpy)3
2+ encapsulating liposomes (ΔEapplied = 1200mV), 
the LODECL was 13 nM[205].  Dr. Olivier Bolduc furthermore investigated the signal 
enhancement factor obtained by employing liposomes instead of a one-to-one analyte to 
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signaling molecule labeling approach, based on the synthesized 200 mM ferri/ferro 
hexacyanide encapsulating liposomes in comparison to 1μM [Fe(CN)6]
4−
.  It was found that 
the data suggest an amplification factor of 5000. 
 
After low signal intensities or, in case of ECL, a non-existent signal at the beginning of the 
studies, the identification of the appropriate liposome, hybridization and flow conditions was 
of great importance.  The proof of principle for DNA detection via the three different 
techniques, fluorescence, EC, and ECL, was only possible after a stable accumulation of the 
magnetic beads at flow rates of over 1 µl/min.  This furthermore allowed for the assay time on 
chip to be reduced to less than 10 minutes on chip, not counting the incubation time, which 
took place outside the chip.  Due to the employment of magnetic beads and thorough washing, 
the chip was reusable.  All these important factors make this a promising novel ECL 
microfluidic biosensor. 
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5. Conclusion 
ECL detection is gaining in importance for biological and clinical sensing, due to its virtually 
zero background, high photon yields, and high sensitivity capabilities.  However, not many 
microfluidic ECL systems detecting DNA have been realized so far.  One limiting factor is 
the identification of signal-enhancing strategies to gain an advantage over other detection 
methods.  Since coreactants and surfactants are known to be capable of enhancing the ECL 
intensity, coreactant-based Ru(bpy)3
2+
 ECL was investigated here with the tertiary amines 
TPA, DBAE and NBEA, under the influence of the surfactants Triton X-100 and Zonyl FSN.  
As already demonstrated for TPA, the addition of a surfactant had an enhancing effect, also 
for NBEA/Ru(bpy)3
2+
 ECL.  NBEA with Zonyl FSN is more effective than NBEA by itself 
for Ru(bpy)3
2+
 ECL, and the most effective coreactant/surfactant combination reported so far. 
However, for DBAE, the signal decreased in the presence of a surfactant, which is surprising 
considering the chemical structure of the three investigated coreactants.  The findings suggest 
that the surfactant interacts in a more complicated manner with the coreactant/Ru(bpy)3
2+
 
system than the general belief of the formation of a hydrophobic layer on the surface of the 
electrode.  Additional factors have to be taken into account, such as the formation of 
ruthenium/coreactant couples that are more likely to occur when both molecules can be 
brought in close proximity with each other.  This is easier to achieve with NBEA under the 
investigated conditions, as with two OH-groups that have a negative partial charge, NBEA 
molecules will be able to approach the positively charged Ru(bpy)3
2+
 complex in closer 
proximity.  Consequently, a general assumption on electrode hydrophobicity influence upon 
the ECL signal cannot be made, but needs to be investigated for each coreactant system 
individually.  We therefore suggest that possible coreactants that have previously been shown 
to have a lower ECL signal than TPA, and therefore have not been further investigated, may 
be worth further testing upon use of Zonyl FSN.  This is especially interesting if additional 
benefits can result, such as a change in potential, higher ECL rates, or a shift in emission 
wavelength, due to the influence of different surfactants.  Also, we can conclude that, in 
general, unless a system is sensitive to the presence of a surfactant, this easy substitute in the 
chemical environment of the ECL reaction can prove beneficial to many ECL assays already 
described in literature, without adding more time or costs to the assay preparation. 
Even though NBEA as coreactant is the least represented in literature compared to the 
common TPA, and even the multiple occasions where DBAE was employed, NBEA also 
proved to be the best choice as coreactant when investigating low oxidation potential ECL.  
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NBEA had not been previously reported to display the capability of LOP ECL.  However, as 
demonstrated here, an ECL signal was observed at voltages well below 1 V, and optimal at 
890 mV under basic pH values and the use of Tris buffer instead of a potassium-based-buffer.  
In the end, the signals obtained for the optimized LOP ECL resulted in a signal almost three 
times higher than those obtained for normal ECL at 1.2V vs. Ag/AgCl using TPA as co-
reactant, which is in standard use in (bio)assays.  The use of Tris buffer at alkaline conditions, 
however, did not only prove beneficial for LOP ECL, but also at the standard 1.2 V vs. 
Ag/AgCl.  While standard ECL is performed with TPA as coreactant, Triton X-100 as 
surfactant in a phosphate-based buffer and at 1.2V, a change to Tris, pH 8.5, NBEA as 
coreactant and Zonyl FSN as surfactant led to about a 3 times higher ECL signal at 1.2V.  
Here, it was observed that Tris was the clearly preferred buffer component, which we assume 
is due to metal complexing capability that positively influences the Ruthenium ECL pathway.  
Further studies, however, are needed to confirm the exact mechanism. We can also conclude 
that the occurrence of strong oxidation peaks in electrochemical CV studies do not necessarily 
translate into an LOP ECL signal. This is important to note, as many studies investigating 
LOP possibilities don’t always correlate electrochemical and ECL signals.  In further studies, 
it will need to be identified how beneficial the lower voltage proves for the stability and 
lifetime of microelectrodes. 
We furthermore demonstrated ECL detection of DNA inside a microfluidic system with an 
integrated three electrode system, consisting of a gold WE and CE and an Ag/AgCl RE.  
Using the appropriate encapsulant conditions, it was possible to form liposomes that 
encapsulated the ECL reagent Ru(bpy)3
2+
 and led to a controlled released inside the chip 
under identified hybridization conditions. First tests led to changes in fluidic and electrode 
design to perform faster assays without the risk of losing the analyte solution.  In the end, on 
chip detection and preparation for reusability was achieved in less than ten minutes, instead of 
forty minutes.  With even further changes to the microfluidic system, as e.g. an even wider 
assembly area in front of the electrodes allowing for faster flow rates, an even faster assay 
time can be reached.  Furthermore, a wider assembly area would allow for on-chip incubation 
of the hybridization assay, avoiding external incubation and sample preparation time.  The 
chip furthermore allowed for fluorescent and EC detection, as successfully demonstrated.  
Since, in subsequent tests, ECL had better limits of detection than fluorescence, but not as 
good as EC detection, it will be necessary to enhance the detection limit and sensitivity for 
ECL by employing a more light-sensitive detector.  While the microscope with CCD camera 
was valuable for preliminary data to gain insight on the signal distribution over the electrodes, 
64 
 
and a magnified view on the electrode itself to detect detachments early, a more powerful 
CCD camera, such as a cooled CCD camera or a high voltage photomultiplier tube (PMT) 
would be highly valuable to lower the limit of detection.  In terms of miniaturization, a 
microsized PIN photodiode should be employed that can be directly attached on top the 
electrodes and ensure stable handling. 
With detection on microfabricated electrodes, and the identification of signal enhancing 
strategies, we demonstrated that ECL is well suited to incorporation into microfluidic devices.  
One key step was the use of Ru(bpy)3
2+
 encapsulating liposomes, as well as the change in 
chemical environment.  The LOD enhancement of a factor of 250 gained by employing the 
newly investigated N-Butyldiethanolamine/Zonyl FSN system, compared to the commonly 
used TPA/Triton system, is not only valuable to our system, but likely beneficial to all 
analytical ECL applications.  For ECL sensors with limited sample size but stringent 
requirements in terms of sensitivity, such as ECL microfluidic DNA biosensors, this easy 
substitution of coreactant/surfactant conditions will prove highly valuable for future and 
existing ECL sensors, and further the use of ECL-based microfluidic applications.  The 
studies demonstrated a significant step towards wide spread applications of sensitive ECL 
based microfluidic point-of-care systems. 
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